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ABSTRACT
Adenosine deaminases that act on RNA (ADARs) deaminate adenosines in double­
stranded RNA (dsRNA) to produce inosines. The extent an adenosine is edited depends 
on the sequence context of the target adenosine. Human ADAR2 (hADAR2) has a 5’ 
nearest neighbor preference of U>A>C>G and a 3’ preference of G>C>U«A, but it is not 
known which amino acids mediate these preferences. Previous studies show that 
preferences are derived mainly from the catalytic domain. Thus, we adapted a previously 
reported screen in yeast to identify mutations in the hADAR2 catalytic domain that allow 
editing of an adenosine in context of a disfavored triplet, GAC. A favored triplet, UAG, 
was used as the positive control. Hairpin substrates containing disfavored GAC and 
favored UAG were based on the R/G editing site of GRIA2 (glutamate receptor, 
ionotropic, AMPA 2) pre-mRNA, a well-studied endogenous substrate for hADAR2.
Four mutants that edited GAC more than WT hADAR2 (E488Q, V493T, N597K 
and N613K) and one mutant that did not edit GAC (T490A) were further characterized 
by determining their binding affinity, catalytic rate, base-flipping and preferences to 
understand the effect of these mutations on ADAR reactivity. Gel-shift assays showed 
two mutants, N597K and N613K, had ~2-fold higher binding affinity compared to WT 
hADAR2, suggesting these mutants may have been selected in the screen due to tighter 
binding. Other mutants E488Q, T490A and V493T, which are on a highly conserved loop
close to the active site, showed similar binding affinity as WT hADAR2 for both UAG 
and GAC, indicating discrimination was not derived from differences in binding affinity.
We also determined catalytic rates, and probed base-flipping by substituting the 
target adenosine with the fluorescent base analog 2-aminopurine (2-AP). Remarkably, 
with both UAG and GAC substrates, mutants with similar binding affinity showed a 
correlation between catalytic rate and base-flipping, as indicated by a change in 2-AP 
fluorescence intensity (FI). Our data provide the first information on the residues 
important for preferences, and point to a conserved loop as key. Unexpectedly, our data 
suggest that hADAR2’s preferences are derived from differences in base-flipping, rather 
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RNA editing refers to a post-transcriptional process where the RNA sequence is 
altered from that encoded by the DNA. RNA editing was first reported in trypanosome 
mitochondria (1), and shortly after RNA editing was also reported in mammals. The three 
major kinds of RNA editing are insertion, deletion and modification of nucleotides. Over 
100 different post-transcriptional modifications have been observed in RNA of which 
pseudouridylation is the most abundant (2, 3). The predominant type of RNA editing in 
mammalian mRNA involves deamination of adenosine to inosine (A-to-I) mediated by 
ADARs (Adenosine deaminases that act on RNA) (4). Another type of mRNA editing 
resulting in nucleotide substitution involves deamination of a cytidine to uridine (C-to-U) 
mediated by APOBEC1 (apolipoprotein B editing catalytic subunit 1). A-to-I RNA 
editing has also been observed in tRNAs, mediated by ADATs (Adenosine deaminases 
that act on tRNAs).
Some RNA editing events increase the diversity of proteins
Several mechanisms are used by organisms to produce functionally different 
proteins from a single gene, thereby increasing the protein diversity. One such
mechanism is the post-transcriptional editing of mRNA. Others include alternative 
splicing, use of alternative promoters, translational frameshifting, and post-translational 
modifications. One well-studied example of editing creating a functionally different 
protein is the C-to-U editing of apolipoprotein B (apoB) mRNA by APOBEC1, a cytidine 
deaminase that acts on RNA (CDAR). Tissue specific editing of this mRNA in the small 
intestine converts a glutamine codon into a stop codon resulting in the formation of a 
truncated apoB 48 instead of the longer apoB 100 (5). The full-length apoB 100 and the 
truncated apoB 48 have different functions in lipoprotein metabolism. Other well-studied 
examples are A-to-I editing within the pre-mRNAs of GRIA (glutamate receptor, 
ionotropic, AMPA 2) and 5-HT2C serotonin receptor (6).
ADARs and their functional domains 
ADARs belong to a family of deaminases that include ADA (adenosine 
deaminases), CDA (cytidine deaminases), ADATs and APOBECs. ADARs convert an 
adenosine into an inosine (Fig. 1.1) in double-stranded regions of pre-mRNAs, non­
coding RNAs and viral RNAs (7-9). Editing in coding regions results in formation of 
multiple protein isoforms due to recognition of inosine as guanosine by translational and 
splicing machinery. Additionally, inosine base pairs with a cytidine, thus an A^U base- 
pair becomes an I^U mismatch and an A^C mismatch becomes an I^C base-pair. Hence, 
A-to-I editing changes the base-pairing potential of the RNA, thereby altering the RNA 
structure. Editing also modulates miRNA biogenesis and targeting (7, 10).
ADARs were initially identified in Xenopus laevis and have been subsequently 





Figure 1.1. ADARs deaminate adenosines to create inosines within double stranded 
regions of RNA. (A) Hydrolytic deamination of adenosine to inosine with the subsequent 
release of ammonia. (B) A cartoon depicting ADARs targeting double-stranded regions 
of RNA.
absent in plants and fungi (7, 9). Usually more than one ADAR is found in an organism.
In mammals, there are three ADAR genes: ADAR1, ADAR2 and ADAR3, and each has 
2-3 double-stranded RNA binding motifs (dsRBMs) on the N-terminus, and a highly 
conserved deaminase domain on the C-terminus (4, 7) (Fig. 1.2). ADAR1 and ADAR2 
are active deaminases, however, no deaminase activity has been observed for ADAR3 
despite the presence of all functional domains (11, 12). ADAR1 and ADAR2 are 
expressed in most tissues, but ADAR3 is expressed exclusively in the brain.
There are two isoforms of ADAR1, generated from alternative promoters: a full- 
length isoform, ADAR1-L, and a shorter N-terminal truncated version, ADAR1-S (13). 
ADAR-1L is expressed from an interferon inducible promoter, whereas ADAR1-S is 
expressed from a constitutive promoter (14). ADAR1-S is initiated from a downstream 
Met codon that excludes an upstream exon due to alternative splicing. ADAR1-L is found 
in both the nucleus and the cytoplasm, whereas ADAR1-S localizes mainly to the nucleus 
(13). Both ADAR1-L and ADAR1-S have an extended amino terminus with Z-DNA 
binding domains (15), however they differ in that ADAR1-L has two Z-DNA binding 
domains, Z a and Zp, while ADAR1-S has only one, Zp. Both B-DNA and A-RNA can 
undergo transitions into left-handed helices, Z-DNA and Z-RNA respectively (16). Z- 
DNA can be formed in vivo from negative super-coiling during transcription and in vitro 
under high salt conditions. On the other hand, Z-RNA formation is less favorable 
energetically than Z-DNA, but evidence suggests Z-RNA is present in both the cytoplasm 
as well as the nucleolus, although its function is not clear (16). Furthermore, the Za 
domain of ADAR1 has been shown to bind Z-RNA suggesting that the in vivo function of 
the Z a domain could be binding Z-RNA (14, 16-18).
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Figure 1.2. Domains of ADAR. (A) Mammalian ADARs have a conserved deaminase 
domain (in blue) at the C-terminus, and either two or three dsRBMs (light brown). 
ADAR1 has one or two Z-DNA binding motifs on the N-terminus, Z-alpha and Z-beta 
(dark brown). Shown in yellow is the arginine rich domain. This figure has been adapted 
from (4).
There are multiple isoforms of ADAR2 produced from alternative splicing events 
(19-21). A novel ADAR2 splice variant, ADAR2-R, found in vertebrates including 
humans and mice, has 49 additional amino acids on the N-terminus, produced by 
incorporating an exon located 18 kilobases upstream of the initially annotated exon one 
(22). This stretch of 49 additional amino acids includes an arginine-rich domain (R- 
domain) similar to that observed in ADAR3 where it binds single stranded RNA. ADAR2 
expression is regulated by CREB (cyclic AMP response element binding), but the mode 
of regulation for ADAR3 is not known (4, 23). On studies with human ADARs, no 
editing activity has been observed with ADAR3 on long synthetic double-stranded RNA 
(dsRNA), or on known endogenous editing sites like the Q/R, R/G and intronic hotspot1 
sites of GRIA2, and the five editing sites of 5-HT2C serotonin receptor (11, 12). However,
ADAR3 reduces the editing efficiency of ADAR1 and ADAR2 in vitro, possibly by 
sequestering the substrates (10).
ADARs have also been studied extensively in Drosophila melanogaster, 
Caenorhabditis elegans and squid. Drosophila melanogaster has a single ADAR gene, 
dADAR, which is homologous to mammalian ADAR2. C. elegans has two ADAR genes, 
adr-1 and adr-2, of which only adr-2 encodes an active deaminase. ADARs are not 
essential in D. melanogaster and C. elegans (7). Squid has two isoforms of ADAR2, 
ADAR2a and ADAR2b, of which ADAR2b is active but ADAR2a is inactive.
Other deaminases
ADA and CDA perform A-to-I and C-to-U deaminations, respectively, of free 
nucleotides. ADATs perform A-to-I deaminations in tRNAs. There are 3 ADATs in 
eukaryotes; ADAT1, ADAT2 and ADAT3. ADAT1 deaminates A37 of tRNAala (24), 
and is not essential. ADAT2/ADAT3 function as a heterodimer and deaminate the 
wobble position (A34) of multiple tRNAs, which leads to altered codon recognition (25); 
this post-transcriptional process is a major determinant of genetic code degeneracy. This 
might explain why ADAT2/ADAT3 are essential. The deaminase domain of 
ADAT2/ADAT3 is more similar to the deaminase domain of CDA than ADA (26), and 
the deaminase domain of ADAT1 is similar to that of ADARs. All ADATs lack dsRBMs.
The APOBEC family includes a number of enzymes, and was named after the first 
family member cloned, APOBEC1, which targets apoB mRNA. APOBEC-1 functions as 
a homodimer, and as part of a multisubunit complex, to perform editing (25, 27). Further, 
APOBEC-1 does not have a separate RNA binding motif like ADARs, instead residues in
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its active site also mediate RNA binding (28). APOBEC2 is a muscle specific protein, 
which is catalytically inactive, whereas AID (activation induced deaminase) and 
APOBEC3 act on ssDNA (29). AID is involved in immunoglobulin class switch 
recombination as well as in the somatic hypermutation that occurs during an immune 
response, while APOBEC3 performs C-to-U deaminations in retroviral DNA replication 
intermediates (25).
ADAR evolution
Phylogenetic analysis suggests that CDA gave rise to ADAT2 and ADAT3, which 
in turn gave rise to ADAT1, and after acquisition of dsRBMs, ADARs were formed. It 
has been proposed that APOBEC1 likely evolved separately from CDA (25, 27).
Sequence alignments have shown that ADARs are also similar to DNA cytosine-5- 
methyl transferases and adenine-N6-amino methyl transferases (30). Thus, ADARs and 
CDAs may be evolutionarily related to methyl transferases, since methyl transferases can 
target both adenine and cytosine.
ADAR editing sites
A-to-I editing in coding regions
Two of the most studied ADAR editing sites are in GRIA2 pre-mRNA. One is the 
Q/R site in exon 11, where A-to-I editing recodes the uncharged Gln (Q) into positively 
charged Arg (R) in the receptor's ion channel, making calcium influx unfavourable. 
Almost 99% of the GRIA2 subunit in the cell is edited to the R form (4, 7). Under-editing 
at this site results in increased calcium influx leading to excitotoxicity and
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neurodegeneration. Editing at the Q/R site also regulates tetramerization of the AMPA 
receptors (31). The second editing site is the R/G site in exon 13, where editing leads to 
formation of a protein isoform with an Arg replaced by a Gly. Editing of the R/G site 
results in a faster recovery rate of the receptor channel after desensitization (32). The R/G 
site is edited by both ADAR1 and ADAR2, whereas the Q/R site is edited solely by 
ADAR2 (33).
Another well-studied example of editing altering coding potential is editing in the 
5-HT2C serotonin receptor pre-mRNA (6). There are five editing sites (A-E) within the 
sequence that encodes amino acids 156-160, and different combinations of editing at 
these sites can result in a total of 24 different protein isoforms (34). These five editing 
sites encode three amino acids within the second intracellular loop of the receptor, which 
is believed to be involved in G-protein coupling. As these sites get increasingly edited, 
the receptors become progressively less active (34). Sites A and B are edited by ADAR1, 
site D is edited by ADAR2, and sites C and E are edited by both ADAR1 and ADAR2 (4).
Rat ADAR2 also edits its own transcript to create an alternatively spliced variant 
that is inactive (35), and hence modulates its own expression.
A-to-I editing in noncoding regions
miRNAs are produced by the sequential cleavage of pri-miRNAs and pre-miRNAs. 
Pri-miRNAs form long intramolecular stem-loop structures in the nucleus, and are 
cleaved by Drosha to produce pre-miRNAs, which are 60-70 nt long. Pre-miRNAs are 
exported to the cytoplasm and further processed by Dicer into mature miRNAs. Since 
dsRNA is targeted by both ADARs, as well as by components of the miRNA biogenesis
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pathway, A-to-I editing modulates the biogenesis and targeting of many miRNAs. For 
example, in vitro studies demonstrate that editing of pri-miR-142 inhibits cleavage by 
Drosha, and consistent with this observation, expression of mature miR-142 is higher in 
ADAR1/ and ADAR2 / mice (36). On the other hand, in vitro studies show that A-to-I 
substitution in pri-miR-151, does not inhibit cleavage by Drosha, but the same 
substitution in pre-miR-151 inhibits cleavage by Dicer (37). Consistent with this 
observation, all the pre-miR-151 detected in human amygdala is edited, whereas no 
mature miR-151 is detected. Further, edited miRNAs may also target a different set of 
mRNAs. For example, studies using an in vivo reporter assay have shown that edited and 
unedited versions of miR-376a target different transcripts (38). Additionally, in vitro 
studies have also shown that A-to-I editing in long dsRNA diminishes its cleavage by 
Dicer, thereby decreasing siRNA production (39).
ADARs are essential in mammals 
Mice with a heterozygous knockout of ADAR1 are viable, but ADAR1'/' 
homozygous embryos die between embryonic day E11.0 and E12.5, and exhibit 
widespread apoptosis in many tissues (40). Disintegration of the liver structure and 
severe defects in hematopoiesis were also observed (41). Similarly, mice with a 
heterozygous knockout of ADAR2 are also viable, but homozygotes die shortly after 
birth between postnatal days, P0 to P20, and becomes increasingly seizure prone after 
P12 (42). The ADAR2'-' phenotype is rescued by substituting both alleles of GRIA2 with 
alleles encoding an edited version of the Q/R site, indicating that GRIA2 pre-mRNA is 
the most important substrate for ADAR2 for viability (42). On the other hand ADAR3 /
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mice are viable, but it is not clear if ADAR1 or ADAR2 compensates for the loss of 
ADAR3 (8).
Involvement of ADARs in diseases 
Aberrant A-to-I editing levels are observed in various diseases. Under-editing of 
the Q/R site of GRIA2 pre-mRNA has been implicated in amyotropic lateral sclerosis 
(ALS) (43, 44). Over-editing of the R/G site of GRIA2 pre-mRNA has been observed in 
epilepsy patients (45). An increase in editing of 5-HT2C serotonin receptor pre-mRNA is 
observed in depression patients and suicide victims (43). However, the cause for these 
aberrant A-to-I editing levels is not understood.
The locus for dyschromatosis symmetrica hereditaria (DSH), a pigmentary 
genodermatosis, maps to the ADAR1 gene (46, 47). To date more than 100 mutations 
have been reported in the ADAR1 gene of DSH patients, and these include missense 
mutations, frame-shift mutations and nonsense mutations. The majority of the mutations, 
at least 47, are missense mutations in the catalytic domain.
ADARs have also been associated with exceptional longevity in humans.
Longevity is strongly familial, and the majority of the genes associated with longevity are 
primarily associated with lipoprotein metabolism and insulin/ IGF-1 signaling (48-50). In 
2009, a study of centenarians showed that 18 SNPs in ADAR2 and ADAR3 genes are 
associated with extreme old age (48).
Consequences of A-to-I editing during viral infections
During viral infections, A-to-I editing by ADARs can increase virus growth in 
certain instances while decreasing it in other instances (14). A-to-I editing of viral RNAs 
by ADARs can be either site-selective, as observed in hepatitis delta virus (HDV), 
Kaposi’s sarcoma associated herpes virus and Epstein-Barr virus, or may be nonselective 
hypermutation that leads to persistence of infection as observed in many viruses.
In the well-studied example of HDV, two forms of delta antigen proteins, which 
are essential for the viral lifecycle, HDAg-S and HDAg-L, are produced from the same 
open reading frame by the inclusion of a stop codon. A-to-I editing within this stop codon 
converts the stop codon into a tryptophan codon allowing translation of the longer 
HDAg-L. The shorter form, HDAg-S, is required for viral RNA replication and the 
longer form, HDAg-L, is required for packaging of the viral genome and assembling new 
viral particles.
An example of nonselective editing is observed in the measles virus, where 
hypermutation in the matrix M gene leads to production of defective M protein that is 
associated with persistence of infection.
ADAR specificity 
ADARs specifically edit certain adenosines over others. There are two 
determinants of specificity: selectivity and preferences. Selectivity refers to the fraction 
of sites edited in a dsRNA, and is dependent on the length of the dsRNA and on the 
presence of bulges, mismatches and internal loops (51). In vitro studies show 
nonselective editing in completely base-paired dsRNA >50 bp, where ~50-60% of
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adenosines are edited at reaction completion. However, adenosines in shorter dsRNA are 
edited more selectively (52, 53). Internal loops convert long dsRNA into shorter stretches 
of dsRNA, possibly by affecting the binding register of ADARs, thereby resulting in 
more selective editing (54). Selective editing in coding regions, results in formation of 
protein isoforms with altered functions. Selective editing is also observed in pri-miRNA 
and pre-miRNA, which affects their processing and targeting. Non-selective editing is 
often observed in noncoding regions of mRNAs, like 5’ and 3’ untranslated regions 
(UTRs) and introns.
The extent of A-to-I editing at a particular site depends on the sequence context of 
the target adenosine, and this specificity is referred to as preferences (55). Human 
ADAR1 (hADARl) and human ADAR2 (hADAR2) have the same 5’ nearest neighbor 
preference of U>A>C>G, and a 3’ nearest neighbor preference of G>C«A>U and 
G>C>U«A, respectively (56). hADARl and hADAR2 truncations comprising only the 
catalytic domain have the same 5’ preference as the full-length proteins, and have a 
similar but distinct 3’ preference of G>C>A>U and C«G«A>U, respectively (56).
Further, when the deaminase domains of ADAR1 and ADAR2 are switched, the substrate 
specificity of the chimeric protein tracks with the protein from which the deaminase 
domain is derived (57). These studies suggest that preferences derive mainly from the 
catalytic domain; however, it is unclear which amino acids in the catalytic domain 
mediate preferences.
ADARs also show preferences for the base opposite the target adenosine (57, 58). 
Thus, C is most favored as the base opposite the target adenosine. A^U is also favored, 
whereas A^ A and A^G are disfavored. This preference for the opposite base is also
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determined by the catalytic domain (57).
Substrate recognition and specificity in other deaminases
Another enzyme that targets mRNA is APOBEC1, which targets apoB mRNA. 
ApoB mRNA has a specific sequence motif that is required for editing by APOBEC-1. 
This sequence motif includes a regulator, spacer and a mooring sequence (27). APOBEC- 
1 acts on ssRNA, whereas ADAR acts only on dsRNA. Hence, although both APOBEC-1 
and ADARs perform deamination reactions on mRNA, they clearly must have different 
mechanisms for substrate recognition.
Interestingly, some APOBECs also have a 5’ neighbor preference, but different 
enzymes in this family have preference for different 5’ neighbors. For example, AID 
specifically targets cytidine with a 5’ purine, whereas APOBEC3 prefers a 5’ pyrimidine. 
Further, different members of the APOBEC3 family have unique 5’ neighbor preferences. 
For example, APOBEC3C targets Y-C dinucleotides, where Y indicates a pyrimidine, 
whereas APOBEC3F targets T-C dinucleotides and APOBEC3G targets C-C 
dinucleotides (59).
ADARs are believed to have evolved from ADATs. The crystal structure of TadA,
Arg2a member of the ADAT2 family in prokaryotes, in complex with a tRNA , showed 
that TadA makes specific contacts with three nucleobases in the anticodon loop and also 
with two flanking nucleobases (60). These nucleobases are splayed, and hence can access 
the specific recognition pockets on the TadA surface. However, ADARs are more similar 
to ADAT1 than ADAT2/ADAT3. Although, both ADAT-1 and ADARs perform A-to-I 
deaminations, and substantial sequence homology is seen in the deaminase domain,
ADAT-1 lacks dsRBMs, and acts on the anticodon loop of tRNA, unlike ADARs, which 
act on dsRNA. Hence, these enzymes also clearly must have different mechanisms for 
substrate recognition and specificity.
Both ADA and CDA deaminate free nucleotides, unlike ADARs, which act on 
dsRNA. Hence, ADARs would not have any similarity to ADA and CDA with respect to 
their mechanism for nearest neighbor specificity.
Crystal structure of the hADAR2 catalytic domain 
The crystal structure of hADAR2 catalytic domain (PDB code: 1ZY7, Fig. 1.3) 
shows the catalytic zinc ion in a deep pocket within a roughly spherical structure, which 
is 40 A in diameter (61). The active site zinc coordinates with two cysteines (C451 and 
C516), one histidine (H394) and a water molecule, which is presumed to displace 
ammonia during the deamination reaction. Residue E396 in the active site hydrogen 
bonds to the zinc coordinated water, and acts as a proton shuttle. Earlier studies had 
shown that equivalent residues in ADAR1 (H910, C966, C1036 and E912) are essential 
for its activity (62). The geometry of zinc coordination observed at the active site of 
ADAR2 is identical to that observed in the active site of CDA, TadA and APOBECs 
(PDB code: 1CTU, 2B3J and 3E1U respectively) (61, 63-66). These enzymes form a 
structurally conserved deaminase motif that includes five P-strands and two a-helices 
(colored blue and numbered as in TadA, Fig. 1.4). The structure of the ADAR2 catalytic 
domain revealed that ADARs are more similar to CDA than ADA. ADAs also perform a 
hydrolytic deamination at the C6 position of adenosine, just like ADARs, however, their 
deaminase motif has a different structural topology comprised of an 8-strand parallel a/p
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Figure 1.3. Crystal structure of hADAR2 catalytic domain. (A) Crystal structure of the 
catalytic domain of hADAR2 (PBD code: 1ZY7)(61) with Zn (pink sphere), IP6 (orange 
and red stick), and modeled in AMP (pink stick). (B) A close view of the active site with 
Zn (pink sphere), modeled in AMP (pink stick), Zn coordinating residues (one histidine 
and two cysteines), proton shuttle (glutamate) and two residues (T375 and R455) close to 
the modeled in AMP. (C) Electrostatic surface potential showing a basic patch on the 
enzyme surface that likely binds dsRNA. The active site Zn (pink sphere) is in a deep 
pocket on the enzyme surface.
16
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Figure 1.4. Crystal structures of deaminases showing the conserved deaminase motif.
(A) The conserved deaminase motif (colored blue) of S. aureus TadA in complex with 
the anticodon stem-loop of tRNAArg2 (PBD code: 2B3J) (60). Five p-strands and two 
helices are numbered as in TadA. (B, C and D) Conserved deaminase motifs of the 
APOBEC3G catalytic domain from E. coli, CDA from E. coli, and the hADAR2 catalytic 
domain, respectively (colored blue, PBD code: 3E1U, 1CTU, and 1ZY7 respectively) (61, 
67, 68). This figure has been adapted from (63).
barrel (63, 64).
C-terminal elements of the deaminase domain of hADAR2 are distinct from those 
of CDA and TadA, and contribute to the formation of an extremely basic cavity that 
buries an inositol hexakisphosphate (IP6) molecule and 29 water molecules hydrogen 
bonded to it. The cavity is lined with basic residues R400, R401, K519, R522, K629, 
K662, K672 and K690, as well as aromatic residues W523, W687, Y658 and Y668 (61). 
The majority of the equivalent residues in ADAR1 are conserved. IP6 is presumed to 
play a structural role by occupying a basic hole in the protein and stabilizing the protein 
fold. It could also be required for catalysis by fine-tuning the environment of the active 
site zinc, since IP6 indirectly coordinates with zinc by a relay of hydrogen bonds 
involving residues K519, D392, K483 and C516 (61). Interestingly, IP6 is also present in 
ADAT1, although it is absent in ADAT2 and ADAT3, indicating that ADARs are more 
similar to ADAT1 than ADAT2 or ADAT3. This is consistent with sequence alignments, 
which indicate that ADARs evolved from ADAT1. Thus, it has been proposed that 
ADAT1 evolved from ADAT2/ADAT3 by acquiring IP6, and further on acquiring 
dsRBMs, ADARs were formed (61).
Mechanism of adenosine deamination by ADAR 
When deamination reactions were performed on dsRNA, with adenosines
13uniformly labeled with C, the resulting inosine retained all labeled carbons (69).
18Further, on performing the deamination reaction in O labeled water, inosines labeled
18with O at the C6 position was observed (69). This indicates that ADARs use a 
hydrolytic deamination mechanism to convert adenosine into inosine, similar to ADA and
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CDA (70), rather than by a base replacement mechanism, which involves breakage of the 
glycosidic bond (69).
Based on the mechanism of other enzymes like CDA and TadA that perform 
hydrolytic deaminations, a similar mechanism has been proposed for ADAR catalysis 
(Fig. 1.5) (33, 63). Residue E396 in the active site of ADAR abstracts a proton from the 
zinc-coordinated water, and the resulting hydroxide attacks the C6 position of adenosine. 
E396 also protonates N1 resulting in the formation of a high energy tetrahedral 
intermediate, followed by proton transfer from O6 to N6, finally yielding inosine by 
releasing ammonia. This proposed reaction mechanism for ADAR is consistent with 
kinetic isotope studies done with an E. coli TadA (71).
The adenosine that undergoes nucleophilic attack during the deamination reaction 
lies deep in the major groove of the dsRNA substrate. Therefore, for this site to be 
accessible to the enzyme, it is presumed that ADARs utilize a base-flipping mechanism, 
whereby the adenosines are flipped into the catalytic pocket. Consistent with this 
mechanism, the active site zinc is in a deep pocket on the enzyme surface, and further, 
the crystal structure shows a basic patch on the enzyme surface (Fig. 1.3C) that likely 
binds dsRNA. A base-flipping mechanism for ADAR was supported by studies with 2- 
aminopurine (2-AP), an adenine analog that is frequently used to probe base-flipping in 
enzymes (72-74).
Mutational analysis of residues close to the active site 
Apart from the zinc coordinating residues and glutamate that are essential for 




Figure 1.5. Proposed mechanism for adenosine to inosine conversion by ADAR.
Residue E396 in the active site of ADAR abstracts a proton from the zinc-coordinated 
water, and the resulting hydroxide attacks the C6 position of adenosine. E396 further 
protonates N1 resulting in the formation of a high energy tetrahedral intermediate, 
followed by proton transfer from O6 to N6, finally yielding inosine by releasing ammonia. 
This figure has been adapted from (63).
structure of hADAR2 catalytic domain that might have a role in the deamination reaction. 
On superimposing the crystal structure of the CDA-zebularine complex (zebularine is a 
cytidine analog and inhibitor of CDA) onto the hADAR2 crystal structure, the ribose of 
zebularine clashes with a loop of hADAR2 that contains the residue T375 (61). Hence it 
has been proposed that this loop could be the reason why ADARs do not deaminate 
cytidine. This clash is absent with the modeled in AMP, since the purine ring of 
adenosine can access the zinc in the active site with a more shallow penetration than that 
required by the pyrimidine ring of cytidine. The crystal structure of hADAR2 with the 
modeled in AMP showed that T375 was in proximity to the 2’-OH of adenosine, and 
residue K376 could possibly interact with the 3’-phosphodiester of adenosine (75). 
Modeling in AMP also required a slight repositioning of the R455 side chain, and this 
side chain is in close proximity to the N7 position of adenosine (61).
The properties of these residues were studied by mutating them into all possible 
amino acids and performing a yeast-based screen to identify the mutants that had editing 
activity. The majority of the active mutants of T375 had small hydrophobic residues at 
this position, although they were less active than the wildtype Thr (75). Large residues at 
this position were inactive, consistent with its proximity to the 2’-OH of the target 
adenosine. When both T375 and K376 were simultaneously mutated into all possible 
amino acids, the majority of the active mutants identified from the screen had a positively 
charged residue at position 376, but at position 375, only Thr and Cys were observed; 
both are amino acids that can hydrogen-bond to the 2’-OH of the target adenosine (75). 
When T375 and R455 were simultaneously mutated, the majority of the active mutants 
had a Thr, Cys or Ser at position 375, while at position 455, small residues (Gly, Ala, Ser,
20
Thr) or Arg were observed (76).
Based on these observations, two roles have been proposed for T375: the first is to 
discriminate the target adenosine from cytidine, and the second is to hydrogen bond with 
the 2’-OH of the target adenosine (63). This residue is not conserved in ADARs; ADAR1 
has an Asn at this position, however, Asn could also possibly form a hydrogen bond with 
the 2’-OH. These data also suggest that although the side chain of R455 is proximal to 
the N7 position of adenosine, this residue is not required for activity (76).
Experimental goals 
Various studies have shown that the extent an adenosine is edited by ADARs 
depends on the sequence context of the target adenosine. However, the mechanism 
underlying nearest neighbor preferences, and the residues in ADAR that confer editing 
site specificity are major outstanding questions. Answering these questions will be crucial 
to understand the basis of altered A-to-I editing levels observed in various diseases and to 
design drugs for specific conditions. In this study, I attempt to answer these questions by 
performing a screen in yeast to identify mutations in the hADAR2 catalytic domain that 
will allow editing of an adenosine within a disfavored context, and further characterize 
these mutants by performing various biochemical experiments to understand the effect of 
these mutations on ADAR reactivity.
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CHAPTER 2
MECHANISTIC INSIGHT INTO ADENOSINE TO INOSINE
__________ __ _ __ *
EDITING SPECIFICITY
Adenosine deaminases that act on RNA (ADARs) deaminate adenosines in double­
stranded RNA (dsRNA) to produce inosines. ADARs are essential in mammals and are 
particularly important in the nervous system. Altered levels of adenosine to inosine (A- 
to-I) editing are observed in several diseases. The extent an adenosine is edited depends 
on sequence context. Human ADAR2 (hADAR2) has 5’ and 3’ neighbor preferences, but 
which amino acids mediate these preferences, and by what mechanism, is unknown. We 
performed a screen in yeast to identify mutations in the hADAR2 catalytic domain that 
allow editing of an adenosine within a disfavored triplet. Binding affinity, catalytic rate, 
base-flipping and preferences were monitored to understand effects of the mutations on 
ADAR reactivity. Our data provide the first information on the amino acids that affect 
preferences, and point to a conserved loop as being of key importance. Unexpectedly, our 
data suggest that hADAR2’s preferences derive from differential base-flipping, rather 
than direct recognition of neighboring bases. Our studies set the stage for understanding 
the basis of altered editing levels in disease and developing therapeutic reagents.
*
Kuttan A & Bass BL (2012) Mechanistic insights into editing-site specificity of ADARs. Proc 
Natl Acad Sci U S A doi: 10.1073/pnas.1212548109
Introduction
ADARs target double-stranded regions of pre-mRNAs, non-coding RNAs, and 
viral RNAs, deaminating adenosines to create inosines (1-3). Inosine is recognized as 
guanosine, and thus, A-to-I editing in a pre-mRNA can alter codons and splice-forms, 
leading to multiple protein isoforms from a single gene. ADARs also alter miRNA and 
endogenous siRNA biogenesis and targeting (2-5). A-to-I editing of viral RNAs can 
reduce virus growth as well as enhance it (6).
ADARs are found in most metazoans, and often more than one ADAR exists in an 
organism. For example, there are three mammalian ADAR genes: ADAR1, ADAR2 and 
ADAR3, and each has two or three N-terminal dsRNA binding motifs (dsRBMs) and a 
highly conserved C-terminal deaminase domain. ADAR1 and ADAR2 are active 
deaminases, but enzymatic activity has not been observed with ADAR3 (2, 7, 8).
Two of the most studied ADAR substrates are the pre-mRNAs of GRIA2 
(glutamate receptor, ionotropic, AMPA 2) and 5-HT2C serotonin receptor. GRIA2 pre- 
mRNA has two editing sites, one that recodes glutamine into arginine (Q/R), and another 
that recodes an arginine into glycine (R/G). Aberrant A-to-I editing is correlated with 
several diseases (9). For example, under-editing of the Q/R site of GRIA2 pre-mRNA is 
implicated in amyotropic lateral sclerosis (ALS) (9, 10), overediting of the R/G site is 
observed in epilepsy patients (11), and an increase in editing of 5-HT2C serotonin 
receptor pre-mRNA is observed in depression patients and suicide victims (9). In 
addition, the locus for dyschromatosis symmetrica hereditaria (DSH), a pigmentary 
genodermatosis, maps to the ADAR1 gene (12, 13). The mechanistic basis for altered 
levels of editing in various diseases is entirely unclear.
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The fraction of sites edited in a dsRNA, referred to as selectivity, depends on its 
length and whether it contains mismatches, bulges and internal loops (3, 14). In vitro 
studies show that nonselective editing occurs in completely base-paired dsRNA > 50 
base-pair (bp), whereas adenosines in shorter dsRNA, or that containing mismatches, 
bulges and loops, are edited more selectively (15-17).
The extent of A-to-I editing at a particular site depends on sequence context, and 
these rules are referred to as preferences (15, 18). Human ADAR1 (hADAR1) and human 
ADAR2 (hADAR2) have a 5’ nearest neighbor preference of U>A>C>G, and a 3’ 
nearest neighbor preference of G>C«A>U and G>C>U«A, respectively (19). Truncated 
forms of hADAR1 and hADAR2 comprising only the catalytic domain have the same 5’ 
preference as the full-length proteins and similar but distinct 3’ preferences (G>C>A>U 
and C«G«A>U, respectively) (19). Further, when the deaminase domains of hADAR1 
and hADAR2 are switched, substrate specificity of the chimeric protein tracks with its 
deaminase domain (20). These studies suggest that preferences derive mainly from the 
catalytic domain. However, it is not known which amino acids in the catalytic domain 
mediate preferences.
To identify the amino acids that mediate preferences, we performed a screen for 
mutations within the hADAR2 catalytic domain that allow editing of an adenosine in a 
poor sequence context. Collectively, the hADAR2 variants we identified point to a 
conserved loop near the active site as important for preferences. Unexpectedly, our data 
suggest that hADAR2’s preferences derive from differential base-flipping, rather than 
direct recognition of the neighboring bases. These studies offer insight in regard to the 





A screen identifies residues in the hADAR2 catalytic 
domain that affect preferences
For both hADAR1 and hADAR2, nearest neighbor preferences derive mainly from 
the catalytic domain (19, 20). A crystal structure of the catalytic domain of hADAR2 has 
been solved (21), and thus, to facilitate our analysis, we focused on this enzyme. We 
adapted a previously reported screen in Saccharomyces cerevisiae (22) to identify 
mutations in the hADAR2 catalytic domain that allow editing of an adenosine in context 
of a disfavored triplet, GAC.
The screen relied on a hairpin-reporter that was introduced into the chromosome of 
the haploid yeast strain, W303a, under the control of a constitutive promoter, ADH1. The 
hairpin (red, Fig. 2.1A), contained an ADAR editing site within a stop codon either in a 
disfavored context, UGAC (Fig. 2.1B), or a favored context, UAG (Fig. 2.1C), and its 
sequence was based on the R/G editing site of GRIA2 pre-mRNA. Editing of either stop 
codon created a tryptophan codon, allowing expression of the downstream a- 
galactosidase reporter, and turning yeast colonies green on X-a-gal plates. The sequence 
upstream of the RNA hairpin (blue, Fig. 2.1A) was the signal sequence for secretion of 
a-galactosidase.
S. cerevisiae lack an ADAR gene, an essential part of the screen. hADAR2 was 
introduced in the low copy CEN-vector to ensure uniform protein expression. Expression 
was under the control of an inducible GAL promoter to facilitate induction by galactose
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Figure 2.1. Mutants that edit the disfavored GAC hairpin were identified from a 
screen in yeast. (A) Schematic of the hairpin-reporter used in the screen. The hairpin, in 
red, is an ADAR substrate with the target adenosine in context of a stop codon that must 
be edited for expression of the downstream a-galactosidase reporter. (B and C)
Sequences of the GAC and UAG hairpins with the target adenosine within a disfavored 
and favored triplet respectively. (D) Control experiments showing CM-URA plates with 
yeast colonies that have either a GAC or UAG hairpin-reporter integrated into a 
chromosome, and transformed with WT hADAR2. (E) Mutants identified from the 
screen, listed left to right in terms of decreasing green intensity of yeast colonies, an 
indication of decreasing in vivo editing efficiency. Green intensity of yeast colonies with 
the control UAG hairpin-reporter is also indicated. “++++” indicates that yeast colonies 
started turning green in < 4 days, “+++” and “++” indicates 5-7 days and “+” indicates 
low levels of editing taking 2-5 weeks to turn faint green. (F) Mutated residues (yellow 
sticks) mapped onto the crystal structure of the catalytic domain of hADAR2 (PBD code 
1ZY7) (21) with Zn (pink sphere), IP6 (orange and red stick), and modeled in AMP (pink 
stick). (G) Alignment of hADAR1, hADAR2, hADAR3, and ADAR2 from different 
species. Mutants that were further characterized are indicated. Highlighted in yellow is 
the highly conserved loop that includes two beta strands and comprises 14 residues.
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LRTKVENGEGT I PV KETSVNWCLADGYDLEILDGT
hADAR2: 480-493 hADAR2: 596-615
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after replica plating. Control experiments established that introduction of WT hADAR2 
into strains containing the hairpin-reporter with the favored UAG editing site (UAG yeast 
strain) allowed expression of a-galactosidase, while introduction into the strain 
containing the hairpin-reporter with the disfavored GAC editing site (GAC yeast strain) 
did not (Fig. 2.1D).
The hADAR2 catalytic domain was randomly mutagenized by error prone PCR to 
attain a mutation rate of 0-4 mutations per kilobase, and introduced into the GAC yeast 
strain in the context of the full-length protein (see Materials and methods). 35,000 
colonies were screened, and 24 positives were obtained that could edit GAC more than 
WT hADAR2. Seven positives had single mutations in the catalytic domain, and E488Q 
was by far the best in this category (Fig. 2.1E). Four mutations appeared more than once, 
suggesting the screen was saturated. Plasmids were also rescued from some white 
colonies, representative of mutants that did not edit GAC, and sequencing verified that 
these were mostly WT hADAR2 or variants with stop codons in the open reading frame. 
One of these, T490A, was at an interesting location between two residues mutated in the 
positives, E488Q and V493A. All mutant forms of hADAR2 were introduced into the 
UAG yeast strain, and all seven positives retained the ability to edit UAG, whereas 
T490A edited UAG poorly (Fig. 2.1E). We did not identify any mutants showing a 
reversed preference, which could edit an adenosine within GAC but not UAG.
When the identified mutations were mapped onto the crystal structure of the 
hADAR2 catalytic domain (21), most mapped onto the surface of the predicted RNA 
binding site (21) (Fig. 2.1F). E488Q, T490A and V493A were on a highly conserved loop 
that includes 2 beta strands and comprises 14 residues (green, Fig. 2.1F; amino acids 480
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to 493, shaded yellow, Fig. 2.1G). Other mutations, A589V, N597K and S599T mapped 
onto another loop and a beta strand on the protein surface (blue, Fig. 2.1F), and N613K 
mapped nearby. Identification of two proximal asparagine to lysine mutations suggested 
that these mutants may have been selected because they improved RNA binding.
Residues N597 and N613 are conserved in ADAR2 from different species, but are 
negatively charged residues in ADAR1 (Fig. 2.1G).
The four mutants that showed maximal editing of GAC, as well as T490A, were 
selected for further characterization. Additional mutagenesis was performed to 
understand the properties required at these positions. PCR libraries encoding all possible 
amino acids at each of the 5 residues were created, and introduced into either the GAC 
yeast strain (E488, V493, N597 and N613; see Materials and methods) or both the GAC 
and UAG yeast strains (T490). At least 15-30 positives and as many negatives were 
selected, sequenced and retransformed into the GAC and UAG yeast strains. Most of the 
negatives had stop codons or frame shifts in the open reading frame.
At position 488, a variety of amino acids were able to substitute for Glu to allow 
editing of UAG, but only Gln and Asn, polar, uncharged amino acids with an amide side 
chain, allowed editing of GAC (Table 2.1). Substituting E488 with large hydrophobic 
residues like Phe, Trp and Leu resulted in loss of editing of both UAG and GAC. We did 
not identify any amino acids at position 490 that allowed editing at GAC. Further, only 
Ser and Cys could replace Thr for editing UAG, suggesting that the predicted hydrogen 
bond (21) from the side chain of T490 to R481 is important. At position 493, a less 
hydrophobic amino acid, Ala, and polar, uncharged amino acids with a hydroxyl side 
chain, Thr and Ser, edited GAC more than the WT Val. At position 597 and 613, only
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Table 2.1. Mutational analysis of mutants identified from the screen
Residue Amino acid substitution a
Editing b
UAG GAC
488 Q (25), N (3) ++++ +++
E (2), A (1), S (1), M (1), R (1) ++++ -
F (1), L (3), W (1) - -
490 T (28), C (8), S (8) ++++ -
A (3) ++ -
F (1), Y (1) + -
R (2), K (1), P (3), E (2) - -
493 T (4), S (13), A (4) ++++ +
V (1), R (1), D (1), P (1), G (1) ++++ -
597 K (19), R (13) ++++ +
N (3), A (1), E (1), H (3), G (1), Y (1) ++++ -
F (2) - -
613 K (6), R (7) ++++ +
N (1), A (1), E (1) ++++ -
a Wildtype residues are in bold, and the number beside each amino acid substitution 
indicates number of clones isolated.
b Extent of editing of UAG and GAC hairpin-reporters in vivo as determined from green 
intensity of yeast colonies on X-a-Gal plates.
positively charged residues, Lys and Arg, allowed editing of GAC, further supporting the 
idea that these residues were selected in the screen due to improved RNA binding.
hADAR2 catalytic domain mutants separate into 
two classes based on binding affinity
WT and mutant hADAR2 proteins were purified to homogeneity (see Materials 
and methods) and subjected to in vitro characterization. We first performed gel mobility 
shift assays comparing the proteins for binding to UAG or GAC hairpins that were
32chemically synthesized and P 5’ end labeled. Representative gel shifts are shown for 
WT hADAR2 and the N597K variant (Fig. 2.2A and B). WT hADAR2 and all mutant 
forms showed the formation of two protein-RNA complexes, as observed in previous 
studies (23). For all proteins tested, a mobility shift was first observed at a protein 
concentration of < 1.5 nM, and at high protein concentrations of ~50 -100 nM, a second, 
slower mobility shift appeared, likely due to a second binding event on the RNA. RNA 
was almost completely bound at a protein concentration of 500 nM. Kd values were 
determined for the complex represented by the first, fast mobility shift, and binding 
isotherms are shown in Fig. 2.2C and D.
WT hADAR2 had a K d  of ~2.1 nM for both UAG and GAC hairpins, emphasizing 
that editing preference for UAG over GAC is not derived from differences in binding 
affinity. Further, all mutants showed a similar binding affinity for UAG and GAC 
hairpins (Table 2.2). E488Q, T490A and V493T showed similar binding affinity as WT 
hADAR2, indicating that these mutations do not affect the binding step. However,
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Figure 2.2. Binding affinity is similar to that of wildtype hADAR2 for some mutants, 
but increased for others. (A and B) Phosphorlmages showing representative gel shift 
assays o f  WT hADAR2 and the N597K  mutant with 20 pM  o f  32P -5’ end-labeled UAG  
and GAC hairpins (Fig. 2.1B and C). Protein concentrations in nM are indicated at the top 
o f  each gel. (C and D) UAG  and GAC hairpin binding isotherms for WT hADAR2 and 
mutant enzymes. Radioactivity corresponding to RNAtotal and RNAfree were quantified 
to determine the fraction bound [Fraction Bound=1 - (RNAfree/RNATotal)]. A ll data 
points were fit using the Hill formalism. Error bars = standard deviation (s.d., n > 3).
Table 2.2. Characterization of hADAR2 WT and mutants
hADAR2 Kd (nM) a d^eam (min ) FI (a.u.) c -O
-
&proteins UAG GAC UAG GAC UA2APG-28 GA2a pC-27
WT 2.1 ± 0.3 2.1 ± 0.3 0.9 ± 0.1 (4.4 ± 0.4) x 10"4 4.6 ± 0.4 1.9 ± 0.1 1.00
E488Q 1.8 ± 0.3 1.8 ± 0.3 > ~2.5 e (2.6 ± 0.3) x 10"2 9.8 ± 0.4 2.6 ± 0.2 0.85
T490A 1.8 ± 0.2 1.8 ± 0.2 (1.2 ± 0.1) x 10"2 U N  f 3.9 ± 0.3 2.0 ± 0.1 1.20
E488Q /T490A 2.1 ± 0.4 1.9 ± 0.4 1.0 ± 0.1 (6.3 ± 0.4) x 10"3 3.9 ± 0.2 2.0 ± 0.1 N D  f
V493T 2.2 ± 0.1 2.6 ± 0.3 > ~2.5 e (2.6 ± 0.3) x 10"3 4.2 ± 0.2 1.7 ± 0.1 N D  f’ g
N597K 0.9 ± 0.1 1.2 ± 0.1 2.3 ± 0.5 (2.3 ± 0.3) x 10"3 N R  f N R  f 0.67
N613K 1.0 ± 0.2 1.2 ± 0.1 1.2 ± 0.2 (1.6 ± 0.2) x 10"3 2.6 ± 0.1 1.6 ± 0.1 0.79
a Kd, dissociation constant for proteins binding U A G  or GAC hairpins. 
b kdeam, rate constant for editing underlined adenosine o f  U A G  and GAC hairpins.
c FI, increase in fluorescence intensity (arbitrary units) on addition o f  protein to U A 2APG-28 or GA2APC-27. FI o f  controls: 
ssUA2apG-28 = 10.2 ± 0.3, duplex UA2apG-28 = 3.7 ± 0.1, ssGA2apC-27 = 9.9 ± 0.3, duplex GA2apC-27 = 3.4 ± 0.2. 
d Srel, Relative nearest neighbor specificity for WT and mutants (Srel = Sprotein/SWT). Nearest neighbor specificity for proteins, for 
example, WT hADAR2, was determined from the equation: SWT = [ 2  | Average %  edited for a triplet -20 | ]WT, which is summation o f  
the absolute values obtained by subtracting 20 from the average % edited for each triplet. Total % editing was normalized to 20% (see 
text and Fig. 2.5).
e Values measured for E488Q and V493T with U A G  were actually 7.3 ± 0.3 min"1 and 3.4 ± 0.3 min"1, respectively. However, in our 
experience the manual pippetting method w e used is inaccurate for values above 2.5 min"1, and a more accurate value must await 
measurement by rapid quench protocols.
f UN=Undetectable, N R  = N ot Relevant and N D  = N ot Determined.
8 Srel = 0.80 for V493A , a different mutation at this position.
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hADAR2, for both UAG and GAC hairpins; this difference was reproducible between 
different experiments and different protein preparations. Possibly, these mutants were 
selected in the screen due to increased binding affinity. Consistent with this idea, both 
residues are on the surface of the protein (21). In the full-length protein used for the gel- 
shift assays, the dsRBMs likely contributed far more to the observed affinity than the 
catalytic domain, possibly masking the full impact of the mutations on interactions with 
the catalytic domain. In fact, a full-length protein containing both mutations, still showed 
only ~2-fold increase in binding affinity compared to WT hADAR2 (Supplementary Fig. 
2.S1A).
However, when we compared truncated proteins, one consisting of the WT 
catalytic domain (truncWT), and the other consisting of the catalytic domain containing 
both mutations (truncN597K/N613K), truncN597K/N613K had ~4-fold higher binding 
affinity than truncWT (Supplementary Fig. 2.S1B and C).
Compared to WT hADAR2, the catalytic rate of E488Q is 
increased and that of T490A is decreased
WT hADAR2 and variants showed similar binding affinity for the UAG and GAC 
hairpins, indicating that discrimination between UAG and GAC occurs after the initial 
binding step. To further understand the basis of preferences, we determined the 
deamination rate (&deam) of WT hADAR2 and mutants under single turnover conditions. 
Slow turnover rate and substrate inhibition of ADARs makes steady state measurements 
challenging (24). We used the same UAG and GAC hairpins for determining deamination 
rate as was used for binding affinity studies, except that the editing site adenosine was
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P labeled at its 5’ phosphate using a splint ligation technique (25). Hairpins were 
incubated with enzyme, and then the RNA was treated with nuclease P1 to produce 
nucleoside 5’-monophosphates, which were separated by thin layer chromatography 
(TLC). Deamination rate was determined by monitoring the amount of 5’-AMP 
converted to 5’-IMP over time.
Representative deamination assays for WT and E488Q mutant hADAR2, using the 
UAG hairpin, are shown (Fig. 2.3A and B), and quantitation of multiple assays for both 
UAG and GAC hairpins plotted (Fig. 2.3C and D). Compared to WT hADAR2, the 
E488Q mutant showed an increase in deamination rate for the UAG hairpin (Table 2.2; 
Fig. 2.3C). V493T and N597K also showed an increase in deamination rate for UAG, 
albeit to a lesser extent than observed with E488Q (Table 2.2; Fig. 2.3C). Dramatically, 
the E488Q mutant showed ~60-fold increase in deamination rate for the GAC hairpin 
compared to WT hADAR2, whereas V493T, N597K and N613K showed only a slight 
increase in deamination rate for this hairpin (Table 2.2; Fig. 2.3D). These data correlated 
with in vivo data obtained from the screen, which showed that E488Q edited GAC most 
efficiently. T490A edited the UAG hairpin poorly, and did not edit the GAC hairpin, 
again correlating with in vivo data. These data indicated that T490 is important for 
wildtype levels of editing, and is involved in a step after the initial binding.
Assays of 2-AP fluorescence suggest certain mutants alter base-flipping
Since the E488Q mutant bound RNA with an affinity similar to that of WT 
hADAR2, its large increase in deamination rate was likely due to a subsequent step. Like 




Figure 2.3. Deamination rates for some mutant enzymes are similar to that of WT 
hADAR2, but others differ. (A and B) PhosphorImages showing representative TLC 
plates used in the deamination rate assay with 250 nM WT hADAR2 or E488Q mutant, 
and 0.5 nM UAG hairpin with the target adenosine labeled at its 5’ phosphate. Time 
points are indicated at the top of the TLC plate, and on the left, positions of origin (O), 5’ 
AMP (pA) and 5’ IMP (pi). Control experiments using less protein or twice the amount 
of RNA confirmed single-turnover conditions (Supplementary Fig. 2.S2), and also 
established that WT and mutant hADAR2 were stable for the duration of the experiment 
(Supplementary Fig. 2.S3). (C and D) Plots showing the fraction inosine produced as a 
function of time for WT hADAR2 and mutants, with UAG and GAC hairpins. Data 
points were fit to the equation, Ft = Fend (1 - e-kt), where Ft is the fraction inosine at time 
t, Fend is the fitted fraction inosine at end point and k  is the fitted rate constant. Error bars 
= s.d. (n > 3). Inset expands the x-axis for reactions with the UAG hairpin, and y-axis for 
reactions with the GAC hairpin. While the overall fit to this equation was good, for the 
UAG hairpin, late time points showed a continued increase in inosine. While this could 
indicate a double exponential rate, the kdeam values obtained on excluding the late time 
points by fitting the data points up to 30 min were similar to that obtained from 60 min 
time points. The small increase at later time points was possibly due to slow editing of
32contaminating P 5’ end labeled 54 nt RNA, used as starting material for preparing the 
60 nt UAG hairpin by splint ligation.
Fraction inosine
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flipping mechanism (24). In another base-flipping enzyme, the cytosine-specific DNA 
methyl transferase M.HhaI, the position occupied by the target cytosine in the DNA 
duplex is assumed by a Gln when cytosine flips out (26). This Gln is flanked by Gly 
residues, proposed to be crucial for positioning the Gln side chain for deep penetration 
into the helix. E488Q also has flanking Gly residues and is on a loop proximal to the 
active site. Thus, we investigated the base-flipping ability of mutants on this conserved 
loop (E488Q, T490A and V493T) by substituting the target adenine with 2-aminopurine 
(2-AP), a fluorescent adenine analog previously used to probe base-flipping (27), 
including in studies of hADAR2 (24).
The fluorescence of 2-AP is dependent on its molecular environment. When 
present in single stranded oligonucleotides, or free in aqueous solution, 2-AP fluoresces. 
However, when incorporated into a double helix, its fluorescence is quenched due to 
base-stacking interactions. Two ADAR substrates were synthesized, with 2-AP in the 
context of favored (UA2APG-28) or disfavored (GA2APC-27) neighbors (Fig. 2.4A).
These substrates were similar to those used for determining binding affinity and 
deamination rate, except the editing site adenine was replaced with 2-AP, and 
intermolecular duplexes were used instead of a hairpin, to enable control experiments 
with single stranded RNA. As expected, in control experiments, single stranded RNA 
with 2-AP showed a dramatic increase in fluorescence intensity (FI) compared to duplex 
RNA with 2-AP (grey dashed and solid lines, Fig. 2.4B and C). However, the 2-AP 
fluorescence in the duplex was not completely quenched, possibly because the 
fluorescence of 2-AP in a mismatch is less effectively quenched than 2-AP in a base pair 
(27). In the absence of protein, UA2APG-28 and GA2APC-27 duplexes showed similar FI,
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Figure 2.4. 2-AP fluorescence assays suggest certain mutants alter base-flipping. (A)
Sequences of constructs used for base-flipping studies, with target adenosines substituted 
by 2-AP (red). UA2APG-28 and GA2APC-27 are intermolecular duplexes made from 
complementary strands of 28 and 27 nts respectively. (B and C) Plots showing FI in 
arbitrary units (a.u.) as a function of wavelength, for samples containing only RNA (0.6 
^M), or both protein (2.4 ^M) and RNA (0.6 ^M) for UA2apG-28 and GA2apC-27. 
Excitation was at 320 nm to minimize background fluorescence from excitation of 
protein residues, and emission was scanned from 335-430 nm. Each spectrum is the 
average of multiple analyses (n > 3), and mean FI at emission maximum and s.d. (error 
bars) is plotted in (D). (D) Dotted lines indicate observed FI of WT hADAR2 with 
UA2APG-28 and GA2APC-27 for reference. Asterisks indicate p-values for the mutants 
compared to WT hADAR2 (* p-value = 0.02, ** p-value = 0.007, *** p-value = 
0.00002). (E) Plot of Pearson product-moment correlation coefficient measuring 
correlation between catalytic rate and FI increase observed with UAG or GAC substrates 
for WT hADAR2 and mutants. UAG substrate data, blue; GAC substrate data, red. 
Correlation coefficient (r) and p-value (p) are indicated. The correlation coefficients for 
UAG substrate data only or GAC substrate data only were also greater than 0.91. (F and 
G) Plot and bar graph showing FI with UA2APG hairpin, analyzed similarly to UA2APG - 
28 duplex.
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as did single stranded UA2jAPG-28 and GA2jAPC-27 (Fig. 2.4D).
All fluorescence measurements were made at saturating protein concentrations. 
When WT hADAR2 was added to the UA2APG-28 duplex, in agreement with previous 
studies (24), FI increased compared to that observed with duplex UA2APG-28 alone (p- 
value = 0.02; Fig. 2.4B, compare solid red and grey lines). Most notably, E488Q showed 
a dramatic increase in FI compared to WT hADAR2 (p-value = 0.00002; Fig. 2.4B, solid 
green versus red lines), suggesting that a Gln at residue 488 enhances base-flipping. Our 
binding studies indicated that T490A has a wildtype affinity for dsRNA (Table 2.2), but 
the FI observed when this protein was added to UA2APG-28 was indistinguishable from 
that of the duplex alone (Fig. 2.4B, solid blue and grey lines). This suggests that T490 
might be required for base-flipping or in a step upstream of base-flipping. V493T did not 
show a statistically significant difference in FI compared to WT hADAR2 (Fig. 2.4B, 
solid pink versus red lines).
Surprisingly, when added to duplex GA2APC-27 (Fig. 2.4C, grey solid line), WT 
hADAR2 and all mutants showed a decrease in FI compared to duplex GA2APC-27 alone. 
Yet, the FI observed with E488Q was higher than that observed with WT hADAR2 
(green versus red lines, p-value = 0.007), suggesting that E488Q also enhances base- 
flipping of adenosine within GAC. These data suggest that the net FI observed in our 
steady-state fluorescence measurements reflects both quenching due to protein binding at 
the mismatched 2-AP, as well as base-flipping. According to this hypothesis, for WT 
hADAR2, E488Q and V493T, base-flipping with the UA2APG-28 duplex is more robust
than that occurring with GA2APC-27 duplex, leading to an increase in FI that
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counterbalances the quenching due to protein binding, producing a net increase in FI 
(Fig. 2.4B). Accounting for both binding and base-flipping in the net FI, might also 
explain the relatively small increase in FI when WT hADAR2 was added to the UA2APG- 
28 duplex, and results with N613K, a mutant with ~2-fold higher binding affinity and 
similar catalytic rate as WT hADAR2. Compared to WT hADAR2, N613K showed ~2- 
fold decrease in FI with UA2APG-28 duplex (compare red and dashed orange lines, Fig. 
2.4B; Table 2.2). Finally, given that T490A exhibits low levels of editing with UAG 
substrates, it likely is capable of base-flipping, albeit inefficiently. We presume that 
effects of this base-flipping on FI are counterbalanced by quenching, so that FI with 
T490A and the UA2APG-28 duplex is indistinguishable from that of the duplex alone.
While our FI measurements likely reflect contributions from both binding and 
base-flipping, for proteins with similar affinity, an increase in FI should correlate with 
increased base-flipping. Consistent with this, we observed a positive correlation between 
increase in FI and catalytic rate for WT and hADAR2 variants with similar affinity 
(Pearson’s product moment correlation coefficient (r) = 0.9248, p-value = 0.0004; Fig. 
2.4E). To confirm that fluorescence experiments performed with duplexes could be 
compared to experiments using hairpins, we incorporated a 2-AP at the editing site of the 
UAG hairpin used in binding and deamination assays. When the UA2APG hairpin was 
mixed with WT hADAR2 and E488Q, we observed an increase in FI comparable to that 
observed with the UA2APG-28 duplex (Fig. 2.4F and G).
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Characterization of the double-mutant E488Q/T490A
Compared to WT hADAR2, the E488Q mutant showed a dramatic increase in FI 
when added to UA2APG-28 duplex, suggesting that Gln at residue 488 affects base- 
flipping. In contrast, when added to this duplex, the T490A mutant exhibited a FI that 
was slightly less than that observed with WT hADAR2 (difference significant at p- 
value=0.02), suggesting that T490 is required for efficient base-flipping or in a step prior 
to base-flipping. We hypothesized that if T490 was essential for efficient base-flipping or 
in a step prior to base-flipping, then the double-mutant, E488Q/T490A, would not exhibit 
the dramatic increase in FI observed with the E488Q mutant.
We first confirmed that binding affinity of E488Q/T490A was similar to WT 
hADAR2 for both UAG and GAC hairpins (Fig. 2.2C and D; Table 2.2). While the 
catalytic rate of the T490A mutant was extremely low for both hairpins, in the context of 
the E488Q/T490A double-mutant, deamination rate increased for both hairpins, but was 
far less than the high deamination rate exhibited by the E488Q single mutant (Fig. 2.3C 
and D; Table 2.2). Further, when the E488Q/T490A mutant was mixed with UA2APG-28 
or GA2APC-27 duplex, the increase in FI was similar to that of T490A, indicating that 
T490 is essential for the increase in FI observed with E488Q (Fig. 2.4B, C and D; Table
2.2). The E488Q mutation could not enhance base-flipping of the T490A mutation, but 
the increased deamination rate of the double-mutant compared to the T490A mutant 
suggested E488Q has an additional role in catalysis.
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hADAR2 specificity is affected by the E488Q and T490A mutations
With WT hADAR2, a protein induced increase in FI was observed with UA2APG- 
28 duplex compared to GA2APC-27 duplex, suggesting that hADAR2’s preference for 
UAG over GAC is derived from differences in base-flipping. Are there other examples 
where the base-flipping efficiency of the enzyme affects specificity? In M.EcoRI, an N6- 
adenine DNA methyl transferase that utilizes a bending, base-flipping and intercalation 
mechanism, a bending deficient mutant decreases base-flipping and increases specificity 
(28, 29). For noncognate substrates, M.EcoRI specificity arises from partitioning the 
enzyme/DNA intermediate into the unbent form (29, 30). We investigated whether 
E488Q and T490A, mutants that showed differences in 2-AP FI compared to WT 
hADAR2, also showed differences in substrate specificity. We determined nearest 
neighbor preferences for all possible sixteen triplet contexts in which the target adenosine 
can occur using a long synthetic, perfectly base paired dsRNA (19). Each protein was 
incubated with non-radiolabeled 418 bp dsRNA to achieve ~20% overall editing; this 
ensured that well edited sites were not saturated to 100% editing, which could result in 
loss of information, and also that the majority of editing sites with a 5’ A were not 5’ I 
(19), which could skew preference determinations.
If hADAR2 lacked preferences, the graphs in Fig. 2.5 would each show a 
horizontal line at 20% editing (see dotted line). However, as illustrated for the WT 
protein, hADAR2, like all ADARs, exhibits preferences, and the line graph is plotted 
with the most preferred triplets to the right of the graph. Consistent with the idea that 
increased base-flipping correlates with a decrease in specificity, for E488Q, most points 
on the line graph moved closer to the dotted line representing 20% editing (Fig. 2.5A).
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Figure 2.5. hADAR2 mutations affect specificity. (A) Plot showing average % editing 
of adenosine in each of the 16 possible triplet contexts, determined from analysis of 
editing in a 418 bp dsRNA, for E488Q compared to WT hADAR2. 196 adenosines were 
used to calculate average % editing of adenosine in 16 triplet contexts. Triplets are 
ordered in terms of 5’ nearest neighbor, with 5’ G followed by C, A and U. Mean % 
editing across 196 adenosines was 19.9% for WT hADAR2 and 21.3% for E488Q, and 
was normalized to 20% as indicated by the dotted line. Error bars = s.d. (n > 3). (B) 
Similar plot as in (A), comparing T490A to WT hADAR2. Sequencing for a portion of 
the antisense strand was not clean for the T490A reactions, so only 153 adenosines were 
used to calculate average % editing of adenosine in 16 triplet contexts for both T490A 
and WT hADAR2. Mean % editing across 153 adenosines was 18.7% for WT hADAR2 
and 19.2% for T490A and was normalized to 20% as in (A). Error bars = s.d. (n > 2). (C) 
As in (A), comparing V493A, N597K and N613K to WT hADAR2. Mean % editing 
across 196 adenosines was 19.6% for V493A, 19.0% for N597K and 20.6% for N613K 









Overall, the E488Q mutant showed more editing for the least preferred triplets (left half 
of the graph) and less editing for the most preferred triplets (right half of the graph), 
although some triplets (CAA, CAC, AAU, UAG) did not follow this pattern. To facilitate 
comparison between enzyme variants, we defined a relative nearest neighbor specificity, 
Srel, and compared to the WT enzyme, the E488Q enzyme exhibited a Srel = 0.85 (Table
2.2). As expected, the E488Q mutant showed a slight to moderate increase in editing of 
all four triplets that had a 5’ G. However, compared to WT hADAR2, only a 1.6-fold 
increase in editing of GAC was observed with E488Q in the 418bp dsRNA, in contrast to 
~60-fold increase in deamination rate observed in the GAC hairpin. Possibly this 
disparity indicates that the mismatched adenosine of the GAC hairpin is more amenable 
to base-flipping than adenosines within the completely base-paired 418 bp dsRNA.
The T490A mutant, on the other hand, showed an overall increase in specificity, 
with Srel = 1.20 (Table 2.2); triplets poorly edited by WT hADAR2 were edited to a 
lower percentage, and triplets well edited by WT hADAR2 were edited to a greater 
percentage (Fig. 2.5B). Mutants V493A, N597K and N613K showed a decrease in 
specificity (Table 2.2); triplets poorly edited by WT hADAR2 were edited more, and 
triplets well edited by WT hADAR2 were edited less (Fig. 2.5C). The decreased 
specificity observed with N597K and N613K could be due to their higher binding affinity 
compared to WT hADAR2.
Discussion
ADARs exhibit nearest neighbor preferences in choosing adenosines for 
deamination. Preferences derive mainly from the catalytic domain (19, 20), but the amino
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acids that mediate preferences, and the mechanism involved, are unclear. We investigated 
these issues by performing a screen for mutations within the catalytic domain that 
allowed editing of an adenosine within a disfavored nearest neighbor context, GAC. We 
identified seven mutations, most of which mapped onto two distinct regions on the 
surface of the predicted RNA binding site (21). We characterized effects of these 
mutations by performing in vitro assays on mutant hADAR2 enzymes, to determine 
binding affinity, catalytic rate, and nearest neighbor preferences. Using a hADAR2 
substrate with the fluorescent analog 2-AP incorporated at the editing site, we also 
compared changes in fluorescence that occurred upon addition of WT or mutant 
enzymes. These data support the idea that ADARs use a base-flipping mechanism to 
access the target adenosine, and unexpectedly, suggest that preferences derive mainly 
from nearest neighbor effects on base-flipping, rather than direct recognition of 
neighboring bases. Our studies provide the first information in regard to the region of 
hADAR2 important for preferences, pointing to a conserved loop on the surface of the 
protein and close to the active site.
Fig. 2.6 presents a model that incorporates the results of our studies. The model 
compares WT hADAR2 with the E488Q mutant, but is consistent with properties of all 
characterized mutations. As illustrated, we observed that WT hADAR2 and the E488Q 
mutant bound the favored UAG and disfavored GAC substrates with identical affinities; 
this was a consistent trend for all mutant enzymes. Even for the two mutants found to 
have a higher affinity compared to the WT enzyme (N597K, N613K), no differences 
were observed between UAG and GAC substrates. Thus, our data indicate that 
preferences do not derive from differential binding. Our model posits that a base-flipping
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Figure 2.6. Model describing preference for adenosine in context of UAG compared 
to GAC, and the role of residues in the conserved loop. (A) Three steps, binding, base- 
flipping and editing are shown for WT hADAR2 and E488Q with UAG and GAC 
substrates. Binding affinities, increase in FI upon mixing enzymes with 2-AP substituted 
UAG or GAC substrates, and catalytic rates are indicated. Binding affinities of WT 
hADAR2 and E488Q are similar for UAG and GAC substrates, indicating that 
discrimination is not derived from differences in binding affinity. In the second step, 
base-flipping is more efficient for adenosine within UAG than within GAC (indicated by 
font size), correlating with increased catalytic rate (third step), and suggesting 
preferences derive from differences in base-flipping. Additionally, E488Q facilitates 
base-flipping, leading to a further increase in catalytic rate for E488Q compared to WT 
hADAR2. In our model, T490 is essential for stability of the active conformation of the 
conserved loop, and a residue on this loop is important for base-flipping. (B) A close 
view of the conserved loop that includes two p strands and comprises 14 residues. 
Hydrogen bonds between the R481 side chain and T490 backbone carbonyl oxygen and 
side chain hydroxyl are shown. Residues E488 and V493 on this loop are also indicated 
(yellow sticks). (C) Cartoon showing all 7 hydrogen bonds within the 14 residues as 
determined in the crystal structure (21). Red dots indicate a hydrogen bond from a side 
chain, with others involving a backbone carbonyl oxygen or amine hydrogen.
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A
step follows binding, and here our experiments with 2-AP suggest a clear difference 
between UAG and GAC substrates. For WT hADAR2 and all studied mutants, a greater 
increase in fluorescence was observed when the protein was mixed with UAG substrates 
compared to GAC substrates, and in all cases this correlated with a higher deamination 
rate (Fig. 2.4D and E). The change in fluorescence was most dramatic with the E488Q 
mutant, suggesting this mutant has enhanced base-flipping properties. Our data suggest 
preferences are based on effects of nearest neighbors on the base-flipping step of the 
ADAR reaction.
We also characterized residue T490, since it was on the conserved loop, proximal 
to other residues identified in the screen (Fig. 2.1F and G; Fig. 2.6B). The mutant T490A 
exhibited a greatly reduced catalytic rate (Table 2.2), and minimal base-flipping that was 
not enhanced in the E488Q/T490A double-mutant. These data suggest that T490 is 
required for efficient base-flipping, and our favored model is that it is important for 
maintaining a conformation of the conserved loop that promotes base-flipping. Indeed, 
the hADAR2 crystal structure shows the side chain hydroxyl and backbone carbonyl of 
T490 hydrogen bonding with the side chain of R481 (21) (Fig. 2.6B and C). 
Correspondingly, R481A did not show editing of adenosine within UAG or GAC 
hairpins in the in vivo a-galactosidase reporter assay (Supplementary Fig. 2.S5). Further, 
in the mutational analysis of residue T490 (Table 2.1), only Ser and Cys could replace 
Thr for editing UAG, suggesting that the predicted hydrogen bond (21) from the side 
chain of T490 to R481 is important (Fig. 2.6B).
The double-mutant E488Q/T490A showed a similar minimal level of base-flipping 
as T490A, but a higher deamination rate than T490A. This suggests that a Gln at 488 has
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effects in addition to enhancing base-flipping. Similar to another base-flipping enzyme, 
M.EcoRI, where enhanced base-flipping compromises specificity (28), the enhanced 
base-flipping of the E488Q mutant correlated with a decreased specificity for most 
triplets (Fig. 2.5A); however, some triplets did not conform, again raising the possibility 
that the E488Q mutation has other effects. Compared to WT hADAR2, only Gln or Asn 
at 488 enhanced GAC editing (Table 2.1), emphasizing the importance of an amide side 
chain for GAC editing. Possibly a hydrogen bond from the amide side chain to the RNA 
promotes this specificity. With E488Q, a small increase in base-flipping of adenosine 
within GAC (FI ~2.6) resulted in ~60 fold increase in editing. This might also indicate a 
Gln at 488 has effects beyond base-flipping, but it is also possible that for GAC, base 
flipping is rate limiting, and a small increase in base-flipping results in a large increase in 
catalytic rate.
2-AP fluorescence is affected by changes in the immediate environment, such as 
alterations in base-pairing or protein interactions (31). The analog is frequently used to 
report on base-flipping (27), including with hADAR2 (24), and in limited cases the 
observed fluorescence changes have been correlated with a crystal structure of 2-AP in a 
flipped out position (32). While we cannot be certain our assays with 2-AP are measuring 
base-flipping, this seems the most likely explanation. The C6 position of adenine that 
undergoes nucleophilic attack during the deamination reaction lies deep in the major 
groove of dsRNA, and as previously proposed (15, 24), it is difficult to imagine anything 
but base-flipping that would allow ADAR access to the C6 atom. Further, the crystal 
structure of the hADAR2 catalytic domain shows a large basic patch on the surface, 
which likely facilitates binding to dsRNA, with a deep pocket that contains the active site
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zinc ion (21), a perfect arrangement for interacting with a helix with a flipped out 
adenosine.
Proven base-flipping enzymes utilize various mechanisms to gain access to a base. 
These include directly pushing it out of the helix with an amino acid (33), the serine 
mediated pinch-pull-push mechanism (34), or the helix bending, base-flipping and 
intercalation mechanism (30). An alternative passive mechanism has also been proposed, 
where the protein simply traps a transiently flipped out base (35). Our studies suggest that 
hADAR2 base-flips an adenosine within a UAG context more efficiently than within a 
GAC context, but further studies will be necessary to determine mechanistic details. If 
ADARs use the passive mechanism, it implies that an adenosine with a 5’ U intrinsically 
flips more readily than an adenosine with a 5’ G. Indeed, NMR experiments and 
theoretical calculations indicate base pair opening probability is affected by nearest 
neighbors (36, 37), and data from such analyses are consistent with ADAR preferences. 
For example, the opening probability of an A^T base pair with a 5’ G is less than that 
with a 5’ C or 5’ T, possibly due to the stronger stacking interaction of adenosine with a 
5’ G (37). Alternatively, base-flipping may be protein induced, but the extent of flipping 
might be influenced by the sequence context. Molecular dynamics simulations suggest 
that, of the two A^C mismatches in the R/G hairpin, adenosine of the target A^C pair is 
more prone to base-flipping than that in the second A^C pair, which is not edited (38). 
Interestingly, the target adenosine has a 5’ A, while the adenosine in the second A^C pair 
has a 5’ G.
The locus for dyschromatosis symmetrica hereditaria (DSH), a pigmentary 
genodermatosis, maps to the hADARl gene (9). Out of more than 100 mutations reported
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in the hADARl gene of DSH patients, at least 47 are missense mutations in the catalytic 
domain (9, 39). DSH is not usually associated with other diseases, but in the two reported 
cases where DSH is accompanied by dystonia, brain calcification and mental 
deterioration, the same mutation, G1007R, was identified (40, 41). The equivalent residue 
in hADAR2 is G487, one of the two Gly residues flanking E488 on the conserved loop. It 
will be informative to study this mutant further to determine if disease symptoms result 
from altered hADAR1 specificity.
Materials and methods 
Construction of hADAR2 plasmids for the screen
The hADAR2 construct includes an N-terminal 12-histidine tag followed by a TEV 
protease recognition site in a yeast expression plasmid YEpTOP2PGAL1 (42). We 
modified this construct to include a restriction site before the catalytic domain 
(YEpTOP2PGAL1-RSinADAR2; Supplementary Methods). Both constructs were cloned 
into the YCp (yeast centromere plasmid) vector with a GAL promoter and URA3 marker 
(YCp-ADAR2 and YCp-RSinADAR; Supplementary Methods).
Construction of hairpin-reporter strains
The plasmid encoding UAG hairpin upstream of the a-galactosidase reporter, 
pR/GaGal, has been described (22). We constructed the plasmid encoding the GAC 
hairpin-reporter by performing sewing PCR, and incorporated the favored six nucleotide 
loop (22) (Supplementary Methods). Both hairpin-reporter constructs were cloned 
separately into the YCp vector with the ADH1 promoter and TRP1 marker, then cloned
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into the corresponding YIp (Yeast Integrating Plasmid) vector (Supplementary Methods). 
YIp vectors containing hairpin-reporters were linearized and integrated into the W303a 
chromosome by lithium acetate transformation (Supplementary Methods).
Screen
YCp-RSinADAR2 was restriction digested to produce a gapped vector lacking the 
catalytic domain (Supplementary Methods). hADAR2 catalytic domain was PCR 
amplified from YCp-ADAR2 (Supplementary Methods), and used as a template for 
random mutagenesis by error prone PCR using the GeneMorph II Random Mutagenesis 
Kit (Stratagene). Amount of DNA template and number of PCR cycles were optimized to 
get 0-4 mutations per kilobase. 100 ng of the gapped vector and 300 ng of random 
mutagenized PCR product were simultaneously transformed with lithium acetate into the 
GAC hairpin-reporter yeast strain, plated on complete minimal (CM)-URA agar plates, 
and incubated at 30 °C for 2 days. Plates were replica plated onto agar plates containing 
CM-URA, 3% galactose, 2% raffinose and 0.06 mg/ml X-a-Gal, and incubated at 20 °C 
for 4-5 weeks. Plasmids were rescued from selected colonies, retransformed into fresh 
GAC hairpin-reporter yeast strains to confirm hADAR2 dependence, and sequenced to 
identify mutations.
Additional mutational analysis for selected residues used the same hADAR2 
catalytic domain template as used for random mutagenesis. We performed sewing PCR 
using two outside primers (CDRanMutP1, CDRanMutP3) and two inside primers specific 
for each mutant (Supplementary Table 2.S1). Inside primers were degenerate, with the 
three nucleotides coding for the relevant amino acid randomized. Mutagenized PCR
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product and gapped vector were transformed into hairpin-reporter yeast strains, as for the 
screen, and analyzed similarly.
Protein purification
Mutants in the YCp vector were cloned back into the yeast expression plasmid, 
YEpTOP2PGAL1 (Supplementary Methods). WT hADAR2 and all mutants (in 
YEpTOP2PGAL1) were purified as described (42) to greater than 97% purity, as 
determined by Coomassie staining. Identity of purified proteins was confirmed by mass 
spectrometry.
Preparation of RNA for in vitro studies
RNA for in vitro studies was chemically synthesized and gel-purified after 
denaturing PAGE (Supplementary Methods). 5’ end labeled hairpins for binding 
experiments were prepared as described (25) (Supplementary Methods). Internally 
radiolabeled hairpins for rate determination were prepared by splint ligation as described
(24) (Supplementary Methods). Duplex or hairpins with the target adenine replaced with 
2-AP were prepared as described (24) with modifications. Purified top and bottom 
strands were dissolved in hybridization buffer (10 mM Tris-HCl (pH 7.5), 0.1 mM 
EDTA, 50 mM KCl), heated to 95 °C for 4 mins, slow cooled to room temperature for 
2hrs, ethanol precipitated and gel-purified after 15% native PAGE. Internally 
radiolabeled, and nonradiolabeled, 418 bp RNA were synthesized as described (19) 
(Supplementary Methods). This dsRNA has a 21 nt overhang at each 5’ terminus. On the 
3’ termini, sense strands had a 12 nt overhang and antisense strands had a 13 nt overhang.
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Gel mobility shift assay
Gel shift assays were as described (23) with modifications. Assays were performed 
with 20 pM RNA and varying protein concentrations, incubated at 4 °C for 20 mins in 
buffer containing 14 mM Tris-HCl (pH 8), 130 mM KCl, 10% glycerol, 1 mM DTT, 100 
^g/ml BSA, 0.2 mM p-mercaptoethanol, 20 mM NaCl. Reaction were stopped by loading 
10 ^l of the reaction directly onto a 6 % (37.5:1 acrylamide/ bis-acrylamide) native gel 
running at 150 V, at 4 °C in 0.5x TBE; gels were electrophoresed for 2 more hrs, dried or 
frozen, and autoradiographed. For truncated proteins, gel shifts were performed as for 
full-length proteins except 35 mM salt and 29:1 acrylamide/ bis-acrylamide was used.
Deamination assay
Deamination assays were performed under single turnover conditions as described
(25), using 0.5 nM RNA and 250 nM protein. Initial experiments with WT hADAR2 and 
UAG substrate at 30 °C resulted in ~60% editing at 20 sec, making it challenging to 
discern differences. Thus, for UAG substrate, all incubations were at 20 °C to slow the 
reaction. For the GAC substrate, incubations were at 30 °C.
2-AP fluorescence assay
2-AP fluorescence experiments were performed on a Perkin Elmer LS 50 
Luminescence Spectrometer at room temperature. Excitation was at 320 nm, emission 
was scanned from 335-430 nm, and a 10 nm slit width was used for excitation and 
emission. Fluorescence was measured using a ultra micro cuvette from Hellma (30 ^l) 
with 2.4 ^M protein and 0.6 ^M RNA in buffer containing 16 mM Tris-HCl (pH 7.5), 8
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mM Tris (pH 8), 20 mM KCl, 40 mM NaCl, 8% glycerol, 1 mM DTT (Roche), 0.01% 
Nonidet P-40 and 0.4 mM p-mercaptoethanol (Sigma). Control experiments used 0.6 ^M 
duplex or single stranded RNA. Corrections were made to emission spectra to account for 
fluorescence from protein and buffer; for RNA only samples, spectrum of buffer was 
subtracted, and for protein-RNA samples, spectrum of protein in buffer was subtracted.
To ascertain that saturating protein concentrations were used, we performed control 
experiments using 3.0 and 1.8 ^M protein instead of 2.4 ^M (Supplementary Fig. 2.S4).
Preference assay
An initial time course was performed as described (19) with internally radiolabeled 
418 bp dsRNA, to determine time required for ~20% editing. Preference assays were as 
described (19) by incubating 0.25 nM non-radiolabeled 418 bp dsRNA and 250 nM 
protein, at 20 °C, for time required to achieve ~20% editing (Supplementary Methods). 
For T490A, incubations were at 30 °C, since 20% editing was not achieved at 20 °C by 1 
hr. For comparison, WT hADAR2 preferences were determined at 30 °C, and found to be 
identical to those at 20 °C.
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Construction of YEpTOP2PGAL1-RSinADAR2. The restriction site, SphI, was 
introduced into YEpTOP2PGAL1 by sewing PCR using primers RSinADAR1up and 
RSinADAR1down, and primers RSinADAR2up and RSinADAR2down (primer 
sequences in Supplementary Table 2.S1). The PCR product and plasmid 
YEpTOP2PGAL1 were then digested with AgeI and BsrGI, followed by ligation to 
produce plasmid YEpTOP2PGAL1-RSinADAR2.
Construction of YCp-ADAR2 and YCp-RSinADAR. ADAR2 genes were 
amplified by PCR using both YEpTOP2PGAL1 and YEpTOP2PGAL1-RSinADAR2 as 
templates, and using primers F1-YCp ADAR2WT and R1-YCp ADAR2WT. Both PCR 
products and the YCp vector were digested with XbaI and EcoRI, followed by ligation to 
produce YCp-ADAR2 and YCp-RSinADAR2.
Construction of pR/GaGal-GAC. GAC hairpin-reporter was constructed by 
performing sewing PCR using primers upLEFT and upRIGHT, and primers downLEFT 
and downRIGHT, with pR/GaGal as template. We further digested the PCR product and 
plasmid with BstXI and SpeI followed by ligation.
Cloning UAG and GAC hairpin-reporters into YIp vector. Both UAG and GAC 
hairpin-reporter constructs were PCR amplified using templates pR/GaGal and 
pR/GaGal-GAC, respectively, and primers F1-YCpaGal and R1-YCpaGal. These PCR 
products and YCp vector were digested with SpeI and XmaI, followed by ligation of the 
insert with the vector. Both YCp vectors containing UAG or GAC hairpin-reporters were 
digested with SacI and KpnI, and the resulting insert containing the ADH1 promoter,
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hairpin-reporter and CYC1 terminator, was ligated with YIp (Yeast Integrating Plasmid) 
that was also digested with SacI and KpnI.
Integration of hairpin-reporter into yeast chromosomes. YIp vectors containing 
either UAG or GAC hairpin-reporters were linearized using restriction enzyme MfeI, 
which cleaves the plasmid in the TRP1 gene. The linearized plasmid was transformed 
into W303a yeast strain by lithium acetate transformation. The W303a strain is 
auxotrophic for TRP1, thus if the linearized plasmid is integrated into the chromosome by 
homologous recombination, the yeast strain becomes prototrophic for TRP1, and can be 
selected on CM-TRP plates. We further confirmed that hairpin-reporters were integrated 
into the chromosome by performing colony PCR with primers YCpaGalSeqP1 and 
YCpaGalSeqP2.
Preparation of gapped vector and template for the screen. YCp-RSinADAR2 was 
digested with SphI and EcoRI to produce a gapped vector lacking the catalytic domain. 
ADAR2 catalytic domain was PCR amplified using YCp-ADAR2 as template and 
primers CDRanMutPl and CDRanMutP3.
Cloning mutants identified in the screen into a yeast expression plasmid. Single 
mutations identified in the screen were subcloned from the YCp vector into 
YEpTOP2PGAL1 using restriction enzymes AgeI and PspXI. To construct the double­
mutant, N597K/N613K, we first created N597K/N613K in YCp, by performing sewing 
PCR using primers CDRanMutPO and N613KP1down, and CDRanMutP3 and 
N613KP3up, with N597K in YCp as template. We further digested the PCR product and 
the plasmid, N597K in YCp, with XmaI and PspXI followed by ligation to produce 
N597K/N613K in YCp. Full-length N597K/N613K and truncN597K/N613K in
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YEpTOP2PGAL1 were constructed by subcloning from N597K/N613K in YCp using 
restriction enzymes, MluI and BstEII.
RNA preparation. To prepare 5’ end-labeled hairpins, chemically synthesized UAG 
and GAC hairpins were gel-purified after 6% denaturing PAGE, 5’ end-labeled using T4
32polynucleotide kinase (New England Biolabs) and y- P ATP (PerkinElmer), passed
through CHROMA SPIN-30 (Clontech) to remove free nucleotides, and separated by 6% 
denaturing PAGE. The appropriate gel band was excised, and extracted overnight in 0.5x 
TBE at 4 oC. RNA was ethanol precipitated, redissolved in refolding buffer (50mM 
HEPES (pH 7.5), 5mM EDTA, 250mM KCl), heated to 95 oC for 4 min, slow cooled to 
room temperature for 2 hr, and again gel-purified from a 6% native polyacrylamide gel.
To prepare internally radiolabeled hairpins, 20 and 22 nt DNA:RNA chimeras were 
separated by 20% denaturing PAGE, 53 and 54 nt RNA and 73 and 76 nt DNA were 
separated by 6% denaturing PAGE, and gel-purified. For UAG hairpin, 100 pmoles of a 
54 nt RNA (5’-AGGUGGGUGGAAUAGUAUACCAUUCGUGGUAUAGUAUCCCA 
CCUACCCAGACGG-3’) was 5’ end labeled as above, passed through CHROMA SPIN- 
10 (Clontech) to remove free nucleotides, extracted with phenol/chloroform/isoamyl 
alcohol, and ethanol precipitated. To this RNA, we added 200 pmoles of a 22 nt 
DNA:RNA chimera, d(CCAGGCGTTTTTGGGT)r(CCGUUU), where the nucleotides 
following “d” are deoxyribonucleotides and those following “r” are ribonucleotides. To 
the above mixture we added 120 pmoles of a 76 nt DNA splint (5’-CCGTCTGGGTAGG 
TGGGATACTATACCACGAATGGTATACTATTCCACCCACCTAAACGGACCCA 
AAAACGCCTGG-3’), volume was brought to 20 ^l with double distilled (dd) water, 
and the mixture heated to 95 oC for 4 min and slow cooled to room temperature (RT) for
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2 hr. To this hybridized mixture, we added 4 pd of 10x T4 DNA ligase buffer (500 mM 
Tris-HCl (pH 7.5), 100 mM MgCfc, 100 mM DTT, 10 mM ATP, 250 ^g/ml BSA), 4 ^l 
of 10 mM ATP, 2 pd RNasin, 6 pd of T4 DNA ligase and 4 pd of dd water to bring the 
volume to 40 pd, and then incubated the mixture at room temperature overnight. Then 2 
pd of RQ1 RNase free DNase was added, followed by incubation at 37 oC for 30 min, and 
products were purified from 6% denaturing polyacrylamide gels. Gel bands were excised, 
extracted overnight in 0.5x TBE at 4 oC, ethanol precipitated, and RNAs refolded as 
described above. To prepare the internally labeled GAC hairpin, we used a 53 nt RNA 
(5’ -ACUGGGUGGAAUAGUAUACCACUCACGGUAUAGUAUCCCACCU 
AGCCGGACGG-3’), a 20 nt DNA:RNA chimera, d(GGCGTTTTTGGGT)r(CCGUUU 
G), and a 73 nt DNA splint (5’-CCGTCCGGCTAGGTGGGATACTATACCGTGAGT 
GGTATACTATTCCACCCAGTCAAACGGACCCAAAAACGCC-3’).
To prepare the 418 bp RNA, sense and antisense strands were synthesized from 
two separate PCR products using T7 RNA polymerase. The PCR products were 
amplified using pSP65 CAT A plasmid as template. pSP65 CAT A plasmid has been 
described (1). Primers 10 and 4 were used to amplify the sense PCR product, and primers 
1and 3 were used to amplify the antisense PCR product (primer sequences in
32Supplementary Table I). For synthesis of internally radiolabeled 418 bp RNA, a- P ATP
(PerkinElmer) was included in the transcription reaction. Equal amounts of sense and 
antisense strands were dissolved in hybridization buffer (10 mM Tris-HCl (pH 8), 40 mM 
KCl), heated to 95 oC for 4 min, slow cooled to room temperature for 2 hr, ethanol 
precipitated and purified from a 4.5% native polyacrylamide gel.
Preference assay. For performing the initial time course with internally
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radiolabeled 418 bp dsRNA, 0.25 nM RNA and 250 nM protein were incubated at 20 oC 
for: 0 sec, 20 sec, 30 sec, 1 min, 5 min, 10 min, 20 min, 30 min, 60 min and 90 min. The 
buffer was that used for deamination assays. The time required to achieve ~ 20% editing 
was determined, and preference assays were performed for the same duration. Editing 
reactions were stopped by addition of 0.5% SDS, heating to 95 oC for 1 min and placed 
on ice. Proteinase K buffer was added (10x stock = 50 mM Tris-HCl (pH 7.5), 50 mM 
NaCl, 5 mM EDTA, 0.5 % SDS and 3.33 ^g/ ^l Proteinase K), incubation was continued 
at 37 oC for 20 min followed by RNA extraction and ethanol precipitation. cDNA was 
made from purified RNA with reverse transcriptase (Thermoscript, invitrogen) using 
primer 6 for sense strands and primer 5 for antisense strands. RNA was removed by 
treating with RNase H, and cDNA was PCR amplified using primers 6 and 12 (sense 
strands), or primers 5 and 7 (antisense strands). Sense and antisense PCR products were 
sequenced with primer 6 and primer 5, respectively (GENEWIZ), and editing sites 
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Supplementary Fig. 2.S1. Binding affinity of truncN597K/N613K is ~4-fold higher
than truncWT. (A and B) PhosphorImages showing representative gel shift assays of 
truncWT and truncN597K/N613K, respectively, with 20 pM of 32P-5’ end-labeled UAG 
hairpin. The dissociation constant, Kd, for truncWT and truncN597K/N613K is 527.5 ± 
14.9 nM and 148.1 ± 1.9 nM, respectively. Protein concentrations (^M) are indicated at 
the top of each gel. Error = s.d. (n > 2). (C) PhosphorImage showing gel shift for full- 
length double-mutant N597K/N613K performed as a control with UAG hairpin. 
Dissociation constant of the double-mutant, N597K/N613K (~1.3 nM) is similar to that 







0.5 nM RNA, 250 nM Protein
0.5 nM RNA, 200 nM protein 
0.5 nM RNA, 100 nM Protein
□





I  0.5 nM RNA, 250 nM Protein, 5 min 
HI 0.5 nM RNA, 200 nM protein, 5min 
LI 0.5 nM RNA, 100 nM Protein, 5 min
■  0.5 nM RNA, 250 nM Protein, 45 min 






Supplementary Fig. 2.S2. Experiments to test single turnover kinetics. (A) Bar graph 
depicting fraction inosine produced for each protein with UAG hairpin, using either less 
protein or more RNA. Measurements were made for the 5 min timepoint. Error bar = s.d. 
(n a 3) for measurements made using 0.5 nM RNA and 250 nM protein, which was used 
for determining the deamination rate, kdeam. (B) Bar graph depicting fraction inosine 
produced with T490A mutant as in (A). All measurements were made at 5 min timepoint, 
except measurements with 1 nM RNA and 250 nM protein which were made at 45 min 
time point. For comparison, the fraction inosine produced at 45 min time point using 0.5 
nM RNA and 250 nM protein (concentrations used for determining deamination rate, 
kdeam) is also plotted. Error bar for this concentration = s.d. (n > 3).
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Supplementary Fig. 2.S3. Confirmation that enzymes retain activity for the course of 
the experiment. (A) Bar graph depicting fraction inosine produced with WT hADAR2 
and mutants without, and with, preincubation for 1 hr at 20 °C prior to incubation with 
UAG hairpin. Incubation was for 10 min in case of WT hADAR2, E488Q, 
E488Q/T490A, V493T, N597K and N613K, and for 30 min with T490A. Error bar = s.d. 
(n a 3). (B) Bar graph depicting fraction inosine produced for E488Q without, and with, 
preincubation for 2 hr at 30 °C prior to incubation with GAC hairpin for 40 min. Error 
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T490A E488Q/ V493T N613K 
T490A
Supplementary Fig. 2.S4. Control experiments with UA2APG-28 to determine 
saturating protein concentrations for the 2-AP fluorescence assay. (A) Bar graph 
depicting increase in FI, in arbitrary units, on addition of 3.0, 2.4 and 1.8 ^M WT
hADAR2 or E488Q to 0.6 ^M UA2apG-28 duplex. 2.4 ^M protein concentration was 
selected for the 2-AP fluorescence assays, and for this concentration, error bar = s.d. (n a 
3). (B) For other mutants, bar graph is plotted depicting increase in FI, in arbitrary units, 
on addition of 2.4 and 1.8 ^M protein to 0.6 ^M UA2APG-28 duplex. For the 2.4 ^M 
protein concentrations, error bar = s.d. (n > 3). Increase in FI with 1.8 ^M protein was 
similar to that determined with 2.4 protein.
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A
Supplementary Fig. 2.S5. In vivo a -galactosidase assay to test editing of UAG with
R481A mutant. (A) CM-URA plates with yeast colonies that have UAG hairpin-reporter 
integrated into the chromosome, and transformed with R481A mutant. WT hADAR2 is 
shown as a control.
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Supplementary Table 2.S1. Primer sequences
Primer name Primer sequences Use
RSinADARlup TCGTCTTCACCGGTCGCGTTCCTGAAACG hADAR2





RSinADAR2down GGTGCT GAT GT ACAGAT GAAAC TGG
F1-Y CpADAR2WT CGGATTCTAGAATGTCACACCATCACCATCACC
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Although it has been known for more than a decade that the extent to which an 
adenosine is edited depends on its 5’ and 3’ nearest neighbors, the residues in ADAR that 
are involved in preferences and the underlying mechanism have long been outstanding 
questions. The studies in this dissertation have identified for the first time, residues in 
hADAR2 that affect preferences, and point to a conserved loop close to the active site as 
being of key importance. Unexpectedly, the studies also suggest that preferences are 
derived from differences in base-flipping rather than direct recognition of the neighboring 
bases. In this section, I will discuss the outstanding questions and the experiments that 
can be performed to address these questions. Additionally, I will discuss the findings in 
this dissertation in the context of previous studies of ADARs and other deaminases, in 
hopes of highlighting how they further our understanding of enzyme mechanism.
Residues in ADAR involved in base-flipping and preferences 
The screen described in this dissertation identified eight mutations in the hADAR2 
catalytic domain that affect preferences. Three mutations, E488Q, T490A and V493A 
were on a highly conserved loop that includes two P-strands (shown in green, Fig. 2.1F).
The E488Q mutant showed an increase in 2-AP FI with both UA2APG-28 and GA2APC- 
27 duplexes, which is suggestive of an increase in base-flipping, and a corresponding 
increase in deamination rate as well. Compared to other mutations characterized, the 
E488Q mutant showed the most dramatic increase in editing in both our in vivo a- 
galactosidase reporter assays as well as in the in vitro single turnover catalytic rate 
determinations, and our data suggest that this increase is due to enhanced base-flipping. 
Therefore, the next obvious questions are: (a) how does a Gln residue at this position 
enhance base-flipping? (b) does this residue facilitate base-flipping directly, or indirectly 
via interactions with other residues ? (c) in the wildtype enzyme does a Glu residue at 
488 mediate base-flipping? Another base-flipping enzyme, cytosine-5 DNA methyl 
transferase M.Hhal, utilizes a Gln (Q237) to flip out the target cytosine by directly 
pushing this cytosine out of the helix (Fig. 3.1) (1). This Gln is flanked by Gly residues, 
proposed to be crucial for positioning the Gln side chain for deep penetration into the 
helix. E488Q also has flanking Gly residues, possibly for similar penetration into the 
helix. Further, looking at the position of E488 in the crystal structure of hADAR2 
catalytic domain with the modeled in AMP (Fig. 2.1F) (2), it is likely that E488Q directly 
flips out the target adenosine. However, an indirect interaction with other residues 
leading to base-flipping cannot be ruled out in the absence of a co-crystal with RNA. 
Since a Glu to Gln mutation at residue 488 enhances base-flipping, it is very likely that 
this residue is also involved in base-flipping in the wildtype enzyme. However, various 
approaches can be utilized to directly address these questions, as well as further our 





Figure 3.1. Crystal structure of M. Hhal. (A) Crystal structure of M. Hhal in complex 
with a 13-mer DNA duplex containing the recognition sequence (PBD code: 1MHT) (1). 
Q237 (yellow stick) pushes the target cytosine out of the helix, and S87 from the catalytic 
loop (pink stick) hydrogen bonds with Q237 to lock the cytosine in a flipped out position.
Co-crystallization of ADAR2 with RNA
Solving a co-crystal of ADAR2 with RNA will be the most conclusive way to gain 
evidence for a base-flipping mechanism by this enzyme, and will also aid in identifying 
or predicting residues that are involved in base-flipping. Co-crystal structures have 
proven base-flipping for various DNA methyl transferases and DNA glycosylases. 
Further, solving a co-crystal of ADAR2 with both favored UAG and disfavored GAC 
duplexes will be very helpful for understanding the mechanistic details of ADAR’s 
preferences. Until now, a crystal structure has only been solved for the catalytic domain 
of hADAR2, and the catalytic domain alone has very weak affinity for RNA. Two of the 
mutants studied in this dissertation, N597K and N613K, have 2-fold higher binding 
affinity than WT hADAR2 for both favored UAG and disfavored GAC hairpins. Further, 
when binding affinities were determined for truncations comprised of only the catalytic 
domains, truncWT and truncN597K/N613K, truncN597K/N613K showed ~4 fold higher 
binding affinity compared to truncWT. Therefore, solving a co-crystal structure with 
truncN597K/N613K is more likely to succeed than with truncWT. Further, as mentioned 
in Chapter 2, if E488Q is stabilizing the flipped out adenosine, then this mutant is also 
more likely to yield a co-crystal than the WT enzyme. In addition, replacing the target 
adenosine with a nonhydrolyzable analog, nebularine, could trap the flipped out 




Time-resolved fluorescence measurements can be made with the same RNA 
duplexes as used in the steady-state fluorescence measurements, where the target 
adenosine is replaced with 2-AP. 2-AP shows a characteristic fluorescence decay on 
flipping out of the double helix, that involves loss of the short decay component (~100 
ps) and increase in amplitude of the long decay component (~10 ns). Our 2-AP 
fluorescence measurements suggest that E488Q enhances base-flipping of the target 
adenosine. However, from the steady state measurements made, it is difficult to 
determine if E488Q is stabilizing the flipped out adenosine, or alternatively, if it is 
increasing the rate of flipping. Performing time-resolved fluorescence measurements will 
be crucial to distinguish between these two possibilities. Further, our data also suggest 
that the 2-AP FI observed in our steady-state experiments reflects both decrease in FI due 
to binding and an increase in FI due to base-flipping. Analysis of time-resolved 
fluorescence measurements will allow the separation of the two components of binding 
and base-flipping, and give a more accurate estimate of base-flipping.
Mutational analysis of residues on the loop
Our studies showed that three residues, E488, T490 and V493, on a conserved loop 
(shown in green, Fig. 2.1F) close to the active site are important for preferences.
Of particular interest is residue E488, since our data suggests that this residue is involved 
in base-flipping. Our mutational analysis of residue 488 using the in vivo a-galactosidase 
reporter assay showed that an alanine at this position cannot edit the disfavored GAC, but 
it can still edit the favored UAG. Further, an asparagine at position 488 can edit both
85
UAG and GAC, similar to a glutamine at this position. However, the a-galactosidase 
reporter assay (X-a-Gal plate assay) used for our screen is not sensitive enough to 
discern 5-10 fold differences in catalytic rates. Hence, these variants must be purified and 
their catalytic rates and base-flipping determined. For example, E488A and E488D could 
be tested to determine if a shorter side-chain will impede base-flipping, using the 2-AP 
fluorescence assay, and if the decreased base-flipping will correlate with reduced activity. 
Although, we identified several mutations at residue 488 that allowed editing of GAC 
and/or UAG using the in vivo a-galactosidase reporter assay, making additional 
mutations at this position that were not initially identified in the screen will be 
informative. Mutating other residues on this conserved loop will be informative as well. 
For example, mutating the Gly residues flanking E488 into a less flexible amino acid will 
be helpful in determining if these Gly residues are required for penetration of E488 into 
the helix.
Is the conformational stability of the conserved loop essential for efficient base- 
flipping? In both the in vivo a-galactosidase reporter assay as well as in the in vitro 
determination of catalytic rate, we found that T490A did not edit adenosine in the context 
of GAC, and poorly edited adenosine in the context of UAG. Correspondingly, the 
T490A mutant also showed minimal base-flipping, as measured by the 2-AP fluorescence 
assay, which was not enhanced in the double mutant, E488Q/T490A. Thus, our data 
suggest that T490 is required for efficient base-flipping, and our favored model is that 
this residue is important for maintaining a conformation of the conserved loop that 
promotes base-flipping. Using a tryptophan fluorescence assay, previous studies with 
hADAR2 have shown that the conformation of the protein changes on binding RNA, in
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particular that of the catalytic domain, since all five tryptophans in hADAR2 are in the 
catalytic domain (5). Thus, a similar tryptophan fluorescence assay could be used to 
determine if the observed conformational change varies between WT hADAR2 and the 
T490A mutant. Additionally, mutational analysis could also be done to gain indirect 
evidence for the importance of the conformational stability of the conserved loop. The 
crystal structure of hADAR2 catalytic domain shows two hydrogen bonds from the 
backbone carbonyl and side chain hydroxyl of T490 to the side chain of R481. Consistent 
with our hypothesis that T490 is required for the conformational stability of this 
conserved loop, we found that the R481A mutant is completely inactive in the in vivo a- 
galactosidase reporter assay. Further, T482 also forms a hydrogen bond from the side 
chain hydroxyl to the backbone carbonyl of another residue, I491, in this loop. Residues 
K483 and E485 in the conserved loop also form hydrogen bonds from their side chains to 
other residues in the protein. Thus, it would be informative to mutate these residues to 
understand their functions in the conserved loop.
The majority of the other mutants identified from the screen were on another loop 
close to the active site (shown in blue, Fig. 2.1F, Fig. 3.2A). This loop is part of a basic 
patch on the enzyme surface observed in the crystal structure of the hADAR2 catalytic 
domain (Fig. 1.3C), suggesting this loop is involved in binding to RNA. Therefore, it will 
be informative to mutate other residues on this loop that were not identified in the screen 
to determine if any of these residues have a role in preferences. Of particular interest are 
residues R590 and K594 that protrude towards the modeled in AMP (Fig. 3.2). It is likely 
that RNA binds to the groove between the two loops (shown in blue and green, Fig. 3.2).
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Figure 3.2. Loops involved in preferences. (A) Close view of two loops involved in 
preferences, which are in close proximity to the active site (PBD code: 1ZY7) (2). 
Important residues on the loops (yellow sticks), Zn (grey sphere) and modeled in AMP 
(pink stick) are shown.
ADAR1 has the same 5’ nearest neighbor preferences as ADAR2, and similar but 
distinct 3’ nearest neighbor preferences. Residues N597 and N613 are conserved in 
ADAR2 from different species, however they are negatively charged residues in ADAR1. 
Hence, it will be interesting to mutate N597 and N613 into negatively charged residues in 
ADAR2 and determine if these residues are responsible for the slight difference in 
preferences between ADAR1 and ADAR2.
Further base-flipping and catalytic rates must be measured with mutated RNA 
hairpins that have the target adenosine in context of other triplets, to determine if our 
theory that preference is derived from differential base-flipping holds true for other 
triplets as well.
Crosslinking using 5-Iodouridine
The residues in close proximity to the 5’ neighbor potentially can be identified by 
substituting the uridine 5’ to the target adenosine with 5-Iodouridine, which is a 
photoreactive chromophore that covalently crosslinks with protein residues upon 
irradiation with UV light. 5-Iodouridine has been used in various studies to identify 
protein residues interacting with substrate DNA or RNA (6-9). Most of the studies have 
identified aromatic residues like tyrosine or phenylalanine as well as basic residues like 
arginine or histidine crosslinked to 5-Iodouridine (10). Preliminary crosslinking 
experiments were performed using UV light at 308 nm wavelength, and under these 
conditions the crosslinked product obtained was <1% of the total RNA. Low crosslinking 
yield is a major problem with this technique. Previous studies have shown that 325 nm 
monochromatic UV light is optimal for crosslinking using 5-Iodouridine, and minimizes 
nonspecific interactions. Therefore, irradiating at 325 nm wavelength using a HeCd laser 
might improve the yield. However, if 5’ uridine is not in close proximity to protein 
residues, then very little or no crosslinked products might be observed.
How are editing sites specifically selected by other deaminases?
As mentioned in Chapter 1, ADA and CDA deaminate free nucleotides, and hence 
will not have a substrate RNA recognition mechanism like ADARs. However, ADATs 
perform A-to-I deaminations in tRNA, and a co-crystal of a prokaryotic TadA, which
Arg2belongs to the ADAT2 family, in complex with tRNA revealed that a loop following 
P-strand 4 (shown in orange, Fig 3.3A) is close to the active site and contacts the 
nucleotide upstream of the target adenosine (3, 11). APOBECs also show preferences for
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Figure 3.3. Crystal structures of deaminases showing loops involved in specificity.
(A, B, C and D) Crystal structures of S. aureus TadA in complex with the anticodon 
stem-loop of tRNAArg2, APOBEC3G catalytic domain from E. coli, CDA from E. coli, 
and hADAR2 catalytic domain respectively (PBD code: 2B3J, 3E1U, 1CTU, and 1ZY7 
respectively) (2, 3, 12, 13). The conserved deaminase motif (colored blue), loop involved 
in specificity in TadA and APOBEC3 (colored orange) (3, 11) and loop involved in 
specificity in hADAR2 (colored green) is shown.
a 5’ flanking nucleotide, and mutational studies in AID and APOBEC3 have revealed 
residues that are involved in specificity. Interestingly, a region that is involved in 
specificity in both AID and APOBEC3 also maps to a loop following p-strand 4 in the 
crystal structures of APOBEC2 and catalytic domain of APOBEC3G (shown in orange, 
Fig 3.3B) (11). However, the loop following p-strand 4 in CDA is further away from the 
active site (shown in orange, Fig 3.3C) (11), consistent with the fact that it acts on free 
nucleotides, and this loop might not be performing a similar function as in TadA and 
APOBEC3.
The crystal structure of ADAR2 catalytic domain also shows this loop to be further 
away from the active site (shown in orange, Fig 3.3D), indicating this loop may not be 
involved in ADAR2’s 5’ neighbor preferences. Studies using an eight-term model have 
shown that although the 5’ neighbor of adenosine is most influential in determining the 
extent of editing, bases further away from the nearest neighbor also contribute slightly 
(14). This could be explained by our model that preferences are derived from differential 
base-flipping, and base-flipping in turn could be affected by neighboring bases. NMR 
experiments and theoretical calculations indicate base pair opening probability is affected 
by neighboring bases (15, 16). However, it will be interesting to analyze this loop 
(residues 548-551, GSLY) to determine if it contributes to preferences as well.
Our studies identified another conserved loop on the surface of the protein and 
close to the active site as important for preferences. Interestingly, this loop is absent in 
TadA as well as APOBECs, consistent with the fact that these enzymes do not have to 
flip the target adenosine to access it, since TadA acts on the tRNA anticodon loop, while 
APOBECs act on ssRNA or ssDNA.
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Are ADARs’ preferences derived from differential base flipping?
WT hADAR2 and all hADAR2 mutants tested, flipped adenosine in the context of 
the favored UAG more than in the context of the disfavored GAC, as indicated by an 
increase in 2-AP FI on addition of protein to RNA that has the target adenosine replaced 
with 2-AP. Base-flipping for all proteins correlated with their respective deamination 
rates. Additionally, an ADAR2 mutant, E488Q, that showed an increased catalytic rate 
with both UAG and GAC, also showed an increase in base-flipping with each of them. 
Thus, whether it is a comparison of the WT protein and mutants, or favored substrate and 
disfavored substrate, in all our experiments, increased catalytic rate correlated with an 
increase in base-flipping, as indicated by an increase in 2-AP FI, suggesting that ADARs 
preferences are derived from differential base-flipping.
Are there other enzymes that affect specificity by modulating base-flipping? In 
M.EcoRI, an N6-adenine DNA methyl transferase that utilizes a bending, base-flipping 
and intercalation mechanism, a bending deficient mutant decreases base-flipping and 
increases specificity (17, 18). For noncognate substrates, M.EcoRI specificity arises from 
partitioning the enzyme/DNA intermediate into the unbent form (18, 19).
ADARs are proposed to have evolved from CDA, however, studies have also 
shown that based on sequence alignments, ADARs are also similar to cytosine-5 DNA 
methyl transferases and N6-adenine DNA methyl transferase (20). Thus, it is possible 
that ADARs utilize a base-flipping mechanism similar to that of methyl transferases, and 
differential base-flipping is responsible for preferences.
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What is the rate-limiting step of the deamination reaction?
Slow turnover rate and substrate inhibition of ADARs make steady state 
measurements challenging (21). Yet, steady state rate measurements using hADAR2 and 
a large excess of a favored substrate (substrate derived from the R/G site of GRIA2 pre- 
mRNA) showed that product formation is linear with time upto three turnovers with no 
burst in product formation (21). This indicates that product release in not the rate-limiting 
step (21). Additionally, it has been proposed that binding and base-flipping are most 
likely not the rate-limiting steps (21-23). Further, studies with substrate analogs suggest 
that the chemical step is rate limiting (22, 23). Since these measurements were made 
using a favored substrate, it is likely that for a disfavored substrate, the rate-limiting step 
may be different.
With E488Q, a small increase in base-flipping of adenosine within GAC (FI ~2.6) 
resulted in ~60 fold increase in editing, whereas a large increase in base-flipping of the 
adenosine within UAG (FI ~9.8) resulted in only ~7 fold increase in editing. This can be 
explained, if we assume that for the disfavored substrate, GAC, the rate-limiting step is 
base-flipping. This is consistent with the fact that neither WT hADAR2 nor mutants 
could flip adenosine within GAC efficiently. The rate of flipping for favored versus 
disfavored substrates can be determined by performing a time-resolved fluorescence 
measurement for each substrate (17, 18), and once the base-flipping rate with each 
substrate is known, by comparison with rates for the chemical step, the rate-limiting step 
can be determined (17, 18).
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Conclusion
It has been known for a long time that the extent to which an adenosine is edited 
depends on the sequence context of the target adenosine. However, the residues in ADAR 
that are involved in preferences and the underlying mechanism have long been an 
outstanding question. The studies in this dissertation have identified for the first time, 
residues in hADAR2 that affect preferences, and point to a conserved loop close to the 
active site as being of key importance. Our studies also suggest that preferences are 
derived from differences in base-flipping rather than direct recognition of the neighboring 
bases. However, many questions still remain regarding the mechanism by which ADARs 
achieve specificity. How do residues on the conserved loop interact with the RNA? Do 
ADARs indeed use a base-flipping mechanism to gain access to a base? If so, what base- 
flipping mechanism do ADARs use? Do ADARs actively push the base out of the helix 
or do they use a passive mechanism? What are the initial events that lead to base- 
flipping? Does the conserved loop have a similar function in ADAR1? What is the cause 
for aberrant A-to-I editing levels observed in diseases? Answering these questions will be 
very helpful in designing drugs for specific conditions.
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APPENDIX A
PURIFICATION OF MUTANT PROTEINS
All mutant forms of human ADAR2 described in Chapter 2 were easily purified 
using the protocol described earlier. As an example, a Coomassie blue stained SDS- 
PAGE analysis of a mutant protein, E488Q, is shown (Fig. A1).








Figure A1. Coomassie blue stained SDS-PAGE analysis of E488Q. Fractions of 
E488Q mutant protein eluted from a Superdex 200 gel filtration column. Molecular 
weight standards (M) and WT hADAR2 (WT) as a reference are indicated.
APPENDIX B
HUMAN ADAR2 CONTAINING THE Y668H MUTATION
During our screen using the a-galactosidase reporter assay, we identified another 
mutant, Y668H, which edited the GAC hairpin-reporter more than WT hADAR2. This 
mutant exhibited low levels of editing of the GAC hairpin-reporter, with yeast colonies 
taking 2-5 weeks to turn faint green, but it edited the UAG hairpin-reporter well in the in 
vivo a-galactosidase reporter assay, similar to WT hADAR2.
As mentioned in Chapter 1, the deaminase domain of hADAR2 has an IP6 molecule 
in a cavity lined with basic and aromatic residues, and Y668 is one of these residues. The 
zinc ion in the active site of hADAR2 is coordinated by a His, two Cys and a water 
molecule. This is unlike most of the zinc containing hydrolases where the zinc is 
coordinated to two or three His. For example, ADA is coordinated to three His, an Asp 
and a water molecule. Among zinc coordinating residues, Cys donates the maximum 
negative charge to zinc, thereby decreasing its Lewis acidity. Thus, substituting His with 
Cys would decrease the positive charge on zinc, and hence increase the pKa of the zinc 
bound water. This would in turn decrease the catalytic efficiency of the reaction. Like 
ADARs, the zinc ion in the active site of CDA is also coordinated to one His, two Cys 
and a water molecule, yet this enzyme efficiently deaminates cytidine, which has been 
proposed to be due to compensating interactions. These compensating interactions could
be provided by the hydrogen bonds from one of the Cys thiolates (C129) to two backbone 
amide groups. However, the analogous Cys in ADAR2 (C451) is hydrogen bonded to 
only one backbone amide group. Thus, the second compensating interaction in ADARs 
could be provided by another zinc coordinating Cys, (C516), which is connected to IP6 
by a relay of hydrogen bonds involving residues K483, D392 and K519. Thus, apart from 
playing a structural role, IP6 could also be required for catalysis by fine-tuning the 
environment of the active site zinc.
Since Y668 directly interacts with IP6, it is possible that the Tyr to His mutation at 
this position increases the positive charge on zinc, thereby decreasing the pKa of water 
coordinated to zinc, which will in turn increase the catalytic rate. If a mutation affects the 
charge on zinc, then it will result in a shift in the optimum pH for that enzyme. Therefore, 
the effect of the Y668H mutation on the charge of zinc could be tested by plotting &deam 
as a function of pH. Potassium acetate buffer could be used to obtain a pH range of 3.8­
5.4 and potassium phosphate buffer could be used to obtain a pH range of 5.8 to 7.5.
If the hypothesis that Y668H increases the positive charge on zinc is true then this 
mutant might slightly increase editing of both UAG and GAC. Since the a-galactosidase 
reporter assay is not sensitive enough to discern small differences in catalytic rates, 
Y668H must be purified and rates determined. We could not purify this mutant protein in 
two attempts using the previously described protocol. Since IP6 has a structural role and 
Y668 interacts directly with IP6, it is possible that mutating this residue decreases the 





Equilibrium experiments were performed to determine the time for which the 
protein and RNA hairpin must be incubated before stopping the reaction by loading 
directly onto a 6 % (37.5:1 acrylamide/ bis-acrylamide) native gel running at 150V. The 
conditions used for the equilibrium experiments were identical to those used for the gel 
shift assays, except that incubations were done for 10 min and 60 min timepoints. Our 
experiments showed that the reactions were at equilibrium at 10 min, and further 
incubation for 60 min did not increase the bound fraction any further. For convenience, a
20 min timepoint was selected for the gel shift assays.
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Figure C1. Equilibrium experiments. (A and B) Equilibrium experiments for WT 
hADAR2 and mutant proteins at 10 min and 60 min timepoints with UAG and GAC 
hairpins respectively.
APPENDIX D
INCUBATION TIMES REQUIRED FOR ACHIEVING ~20 % 
EDITING OF A 418 bp dsRNA
An initial time course was performed as described (see Chapter 2, supplementary 
methods) with internally radiolabeled 418 bp dsRNA, to determine the time required to 
achieve ~20% overall editing. Once this time was determined, preference assays were 
performed for the same duration. The incubation time, incubation temperature and the 
average % editing for WT and mutant proteins in the preference assay are shown in Table 
D1.







WT ~ 11 min 20 oC 19.9
E488Q ~ 6 min 20 oC 21.3
V493A ~ 12 min 20 oC 19.6
N597K ~ 16 min 20 oC 19.0
N613K ~ 13 min 20 oC 20.6
A589V ~ 14 min 30 oC 20.0
G336D ~ 17 min 30 oC 19.4
E488Q/T490A ~ 26 min 20 oC 25.1
WT ~ 5 min 30 oC 18.7
T490A ~ 56 min 30 oC 19.2
APPENDIX E
PREFERENCE ASSAYS OF A589V, G336D AND THE 
DOUBLE MUTANT E488Q/T490A
All preference assays were performed and analyzed as mentioned in Chapter 2 for 
WT hADAR2 at 20 °C, and are shown in Fig. S3. Surprisingly, A589V did not show an 
increase in editing of GAC, although it was selected for editing GAC in the a- 
galactosidase reporter assay. Rather, it showed a small decrease in editing of GAC. This 
could be because of many reasons: firstly, the a-galactosidase reporter assay was done 
using the UAG hairpin, whereas for the preference assay we used a 418 bp dsRNA. 
Therefore, it is possible that compared to WT hADAR2, this mutant increased editing of 
the UAG hairpin slightly, but it could not edit UAG in a perfectly base paired duplex as 
well. Secondly, even in the a-galactosidase reporter assay this mutant exhibited low 
levels of editing of the GAC hairpin-reporter, with yeast colonies taking 2-5 weeks to 
turn faint green. Therefore, it is possible that A589V was selected in the screen due to the 
fact that the screen is not as sensitive as the in vitro assays. A589V could have been 
selected also due to human error, since we did not use a colorimetric assay for detection 
of a-galactosidase, and the green yeast colonies were picked visually.
Overall A589V showed a small increase in specificity, Srel = 1.16 (Srel has been 
defined in Chapter 2) (Table S2); triplets poorly edited by WT hADAR2 were edited
almost to the same extent, however, triplets well edited by WT hADAR2 were edited to a 
greater percentage by the A589V mutant.
The G336D mutant, on the other hand, showed similar specificity as WT hADAR2, 
with Srel = 0.96 (Fig. S3, Table S2); most of the triplets were edited to the same extent as 
observed with WT hADAR2. However, compared to WT hADAR2, G336D showed a 
slight increase in editing of GAC. In the case of the double mutant E488Q/T490A, most 
of the triplets were edited to a level intermediate between that observed with E488Q and 
T490A mutants alone, with Srel = 0.97.











Figure E1. Preference assays. (A) Plot showing average % editing of adenosine in each 
of the 16 possible triplet contexts, determined from analysis of editing in a 418 bp 
dsRNA, for A589V and G336D compared to WT hADAR2. 196 adenosines were used to 
calculate average % editing of adenosine in 16 triplet contexts. Triplets are ordered in 
terms of 5’ nearest neighbor, with 5’ G followed by C, A and U. Mean % editing across 
196 adenosines was 19.9% for WT hADAR2, 20.0% for A589V and 19.4% for G336D, 
and was normalized to 20% as indicated by the dotted line. Error bars = s.d. (n > 3). (B) 
As in (A), comparing E488Q/T490A to WT hADAR2. Mean % editing across 196 
adenosines was 25.1%.
APPENDIX F
SEQUENCE OF 418 bp dsRNA USED FOR PREFERENCE ASSAYS
Sense strand:
5’ -GTAGCCTTGAGCTTGGATCTGCCCAGCTTGGCGAGATTTTCAGGAGCTAAG
GAAGCTAAAATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCC
AATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACC
TATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGA
AAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATG
AATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATAT
GGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTT
TCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATA
TTCGCAAGATGTGGCGTGTTCGTTGCTCCTAA-3’
Antisense strand:
5’ -GATAGGCCAGGTTTTCACCGTAACACGCCACATCTTGCGAATATATGTGTA
GAAACTGCCGGAAATCGTCGTGGTATTCACTCCAGAGCGATGAAAACGTTTC
AGTTTGCTCATGGAAAACGGTGTAACAAGGGTGAACACTATCCCATATCACC
AGCTCACCGTCTTTCATTGCCATACGGAATTCCGGATGAGCATTCATCAGGCG
GGCAAGAATGTGAATAAAGGCCGGATAAAACTTGTGCTTATTTTTCTTTACGG
TCTTTAAAAAGGCCGTAATATCCAGCTGAACGGTCTGGTTATAGGTACATTGA
GCAACTGACTGAAATGCCTCAAAATGTTCTTTACGATGCCATTGGGATATATC
AACGGTGGTATATCCAGTGATTTTTTTCTCCATTTTAGCTTCCTTAGCTCCTGA
AAATCTCGCCAAGCTGGGATCCAAACCTGAA-3’
